Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lordstown Motors, Root, Vroom, and Repro Med and Encourages Investors to Contact the Firm

NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lordstown Motors Corp. (NASDAQ: RIDE), Root, Inc. (NASDAQ: ROOT), Vroom, Inc. (NASDAQ: VRM), and Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Lordstown Motors Corp. (NASDAQ: RIDE)

Class Period: August 3, 2020 to March 24, 2021

Lead Plaintiff Deadline: May 17, 2021

According to its website, Lordstown is an automotive company founded for the purpose of developing and manufacturing light duty electric trucks targeted for sale to fleet customers. The Company’s purported flagship vehicle is the “Endurance,” an electric full-size pickup truck.

On March 12, 2021, analyst Hindenburg Research published a scathing report on Lordstown entitled: “The Lordstown Motors Mirage: Fake Orders, Undisclosed Production Hurdles, and a Prototype Inferno.” In this report, Hindenburg noted that Lordstown has “no revenue and no sellable product,” and wrote that the Company “has misled investors on both its demand and production capabilities.” The Hindenburg report concluded that Lordstown’s “orders are largely fictitious and used as a prop to raise capital and confer legitimacy,” and that a former employee “explained how the company is experiencing delays and making ‘drastic’ design modifications, putting [Lordstown] an estimated 3-4 years away from production,” rather than the Company being “on track” for a September 2021 production start.

On this news, the price of Lordstown common stock fell approximately 16.5% in one day, down from its March 11, 2021 closing price of $17.71 to a March 12, 2021 close of just $14.78. This represents hundreds of millions of dollars in lost market capitalization.

Then on March 17, 2021, after trading had closed, the Company held an earnings call disclosing that Lordstown had received an inquiry from the SEC. Remarkably, although Lordstown also issued a press release and a Form 8-K announcing its fourth quarter and full year 2020 financial results after trading closed on March 17, 2021, the Company failed to disclose the existence of the SEC inquiry in those filings.

On this news, the stock fell approximately another 9% in aftermarket trading.

The complaint, filed on March 18, 2021, alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Company’s business. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s purported pre-orders were non-binding; (ii) many of the would-be customers who made these purported pre-orders lacked the means to make such purchases and/or would not have credible demand for Lordstown’s Endurance; (iii) Lordstown is not and has not been “on track” to commence production of the Endurance in September 2021; (iv) the first test run of the Endurance led to the vehicle bursting into flames within 10 minutes; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

For more information on the Lordstown Motors class action go to: https://bespc.com/cases/RIDE

Root, Inc. (NASDAQ: ROOT)

Class Period: Securities purchased between October 28, 2020 and March 8, 2021, both dates inclusive (the “Class Period”); and/or Root Class A common stock pursuant and/or traceable to the offering documents issued in connection with the Company’s initial public offering conducted on or about October 28, 2020 (the “IPO” or “Offering”).

Lead Plaintiff Deadline: May 18, 2021

On October 5, 2020, Root filed a registration statement on Form S-1 with the SEC in connection with the IPO, which, after several amendments, was declared effective on October 27, 2020 (the “Registration Statement”). On October 28, 2020, Root conducted the IPO, selling 26.8 million shares of the Company’s Class A common stock to the public at $27.00 per share for total approximate proceeds of $724.43 million. 

On March 9, 2021, Bank of America (“BofA”) Securities analyst Joshua Shanker (“Shanker”) initiated coverage of Root with an “Underperform” rating on the premise that the Company is unlikely to be cash flow positive until 2027, finding that Root “will require not insignificant cash infusions from the capital markets to bridge its cash flow needs.” Shanker also noted that insurers Progressive, Allstate, and Berkshire Hathaway’s Geico would continue to impede the Company’s profitability, with Progressive and Allstate having a “sizable advantage over Root in terms of amount of [telematics] data as well as engagement with the data” used to price their auto insurance.

On this news, Root’s stock price fell $0.18 per share, or 1.46%, to close at $12.17 per share on March 9, 2021, representing a total decline of 54.93% from the Offering price.

The complaint, filed on March 19, 2021, alleges that the offering documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, throughout the Class Period, defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, the offering documents and defendants made false and/or misleading statements and/or failed to disclose that: (i) Root would foreseeably fail to generate positive cash flow for at least several years following the IPO; (ii) accordingly, the Company would foreseeably require significant cash infusions to meet its cash flow needs; (iii) notwithstanding the defendants’ touting of Root’s purportedly unique, data-driven advantages, several of the Company’s established industry peers in fact possessed significant competitive advantages over Root with respect to, inter alia, telematics data and data engagement; and (iv) as a result, the offering documents and defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

For more information on the Root class action go to: https://bespc.com/cases/ROOT

Vroom, Inc. (NASDAQ: VRM)

Class Period: June 9, 2020 to March 3, 2021

Lead Plaintiff Deadline: May 21, 2021

On March 3, 2021, Vroom announced its fourth quarter and full year 2020 financial results in a press release. Therein, the Company reported that fourth quarter “Ecommerce Vehicle gross profit per unit decreased 13.1% to $878, driven primarily by lower sales margins, partially offset by improvements in inbound logistics and reconditioning costs per unit.” Vroom also reported that for the fourth quarter, its “[n]et loss increased 41.9% to $60.7 million.”

On this news, the Company’s stock price fell $12.29 per share, or 27.9%, to close at $31.61 per share on March 4, 2021.

The complaint, filed on March 22, 2021, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products; (2) that, as a result, the Company was forced to discount aged inventory to move through its retail channels or liquidated in its wholesale channels; (3) that, as a result, the ecommerce gross profit per unit was reasonably likely to decline; and (4) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

For more information on the Vroom class action go to: https://bespc.com/cases/VRM

Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD)

Class Period: August 4, 2020 to January 25, 2021

Lead Plaintiff Deadline: May 25, 2021

KORU designs, manufactures, and markets proprietary portable medical devices, primarily for the ambulatory infusion market.

On November 3, 2020, after the market closed, KORU announced its third quarter 2020 financial results, reporting that net sales declined sequentially to $6.1 million. During the conference call the next day, the Company attributed the lower sales to, among other things, “higher allowances for gross rebates for certain customers” and “payment discounts and distribution fees.”

On this news, the Company’s stock fell $1.97, or 32%, to close at $4.16 per share on November 4, 2020.

On January 25, 2021, after the market closed, KORU announced its preliminary financial results for fiscal 2020, expecting revenue of approximately $24.0 million, an increase of 3.4% over the prior year. The Company attributed the results to, among other things, “[s]lower growth in net revenue as a result of strengthening our contractual position with large customers.” In the press release, KORU also announced that its CEO, Donald Pettigrew, resigned, effective immediately.

On this news, KORU’s stock price fell $0.80 per share, or 15.5%, to close at $4.33 per share on January 26, 2021.

The complaint, filed on March 26, 2021, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors that: (1) starting in January 2020, KORU ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, the Company’s net sales were reasonably likely to decline; and (3) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

For more information on the Repro Med class action go to: https://bespc.com/cases/KRMD

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com



Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021

Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021

MONROVIA, Calif.–(BUSINESS WIRE)–
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that it will release first quarter 2021 financial results after the market closes on Wednesday, May 5, 2021.

Xencor management will host a webcast and conference call the same day at 4:30 p.m. ET (1:30 p.m. PT) to discuss the financial results and provide a corporate update.

The live call may be accessed by dialing (877) 359-9508 for domestic callers or (224) 357-2393 for international callers and referencing conference ID number 2378094. A live webcast of the conference call will be available under “Events & Presentations” in the Investors section of the Company’s website located at www.xencor.com. The webcast will be archived on the company website for 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 21 candidates engineered with Xencor’s XmAb® technology are in clinical development internally and with partners. Xencor’s XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

Charles Liles

[email protected]

Media Contact

Jason I. Spark

Canale Communications

619-849-6005

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Oncology

MEDIA:

Logo
Logo

Align Celebrates 10 Million Invisalign Smiles With 10 Million Thanks – Donates $10 Million to the Align Foundation to Fund Organizations That Transform Smiles, and Support and Educate Teens

Company hopes to inspire others to share their smiles using #10MInvisalignSmiles

  • 10 millionth Invisalign milestone reflects accelerating pace of adoption of Invisalign treatment driven by continued global expansion and investments in digital technologies including the iTero intraoral scanner
  • 10 millionth Invisalign patient is Gabriela Silva from São Paulo, Brazil who has just begun treatment with Dr. Eunice Blind, a orthodontist practicing at Clinica Pedroso, also in São Paulo
  • Align partners with Por 1 Sorriso, a Brazilian non-governmental organization (NGO) to help create even more smiles in socially vulnerable communities

TEMPE, Ariz. and SAO PAULO, Brazil, April 28, 2021 (GLOBE NEWSWIRE) — Align Technology, Inc. (Nasdaq: ALGN) today announced that over 10 million patients have begun treatment with the Invisalign system – the most advanced clear aligner system in the world – including 2.6 million teenage patients*. This is a significant milestone for the company and the Invisalign-trained orthodontists and dentists worldwide who trust Invisalign clear aligners to treat adults, teens, and patients as young as 6 years old.

Commenting on the 10 millionth Invisalign patient milestone, Joe Hogan, Align Technology CEO, said, “It’s remarkable to think about the pace of growth and adoption that we are experiencing worldwide, especially when considering it took 10 years to achieve our one millionth Invisalign patient milestone and now we are adding one million new Invisalign patients in less than six months. We are grateful to our doctor partners and their patients, and to our 20,000 employees around the world who have helped us reach this milestone. In recognition of our 10 millionth Invisalign milestone, we have donated $10 million to the Align Foundation donor-advised fund to support organizations whose visions tie closely to our own: transforming smiles and changing lives, supporting and educating teens, and empowering our doctor customers through partnerships with learning institutions and foundations. We are also kicking off a campaign called “10 Million Smiles. 10 Million Thanks” centered around the transformative power of Invisalign treatment through the eyes of Invisalign patients. This is our way to say thank you and inspire others to share their smiles with the world using #10MInvisalignSmiles.”

To join in the global celebration, tag yourself using #10MInvisalignSmiles on social media and share a smile selfie, story or video with the world.

“I’m honored to be the 10 millionth Invisalign patient and very excited about improving my smile with Invisalign aligners,” said Gabriela Silva, the 10 millionth Invisalign patient. “As part of my job, I’m in front of people all the time and my smile and ability to communicate are very important to me. After searching for different options, I selected Invisalign treatment because I could improve my smile with minimal impact to the way I look or how I speak. My experience with Dr. Blind has been amazing so far and I know that she will be with me each step of the way. Dr. Blind has a very modern practice with a fun and experienced staff and lots of high-tech equipment. I was impressed that she was able to show me before and after Invisalign images using the iTero scanner which helped me visualize how my smile would look after treatment. I can’t believe that in only eight months, I can get a brand new smile that will increase my self-confidence without disrupting my daily routine. Even my husband asks from time to time if I’m wearing my aligners or not. It’s really funny coming from someone who knows me so well and sees me everyday!”

“I was delighted to learn that my patient, Gabriela Silva, is the 10 millionth Invisalign patient,” noted Dr. Eunice Blind. “Invisalign treatment is totally revolutionary and the ability to anticipate the results and share visuals with patients before treatment has even started gets them really excited. When patients see a simulation of themselves and what can be achieved with Invisalign aligners, they get even more motivated to commit themselves to treatment — something that is not possible with traditional orthodontics. As an orthodontist practicing in São Paulo, Brazil for the past six years, I know first hand how digital technologies like the Invisalign system and the iTero scanner are revolutionizing orthodontics. These technologies have changed our clinic completely and took us once and for all to the flow of digital dentistry.”

In addition to the $10 million contribution to the Align Foundation, Align is partnering with Brazilian NGO Por 1 Sorriso (“For 1 Smile”) to help create even more smiles by sponsoring their mission of better health and well-being through access to dental and medical care in underprivileged communities. As part of the sponsorship, Por 1 Sorriso will develop doctor-engaged events over the course of a year starting with an event on May 29 in São Paulo, with dental and medical assistance to homeless residents and the local community of São Paulo city.

“I am excited and proud to have Brazilians Gabriela Silva and Dr. Eunice Blind represent Align’s 10 millionth Invisalign patient milestone,” said Ritesh Sharma, Align vice president and general manager, Latin America. “Latin America represents a tremendous growth potential for Align and celebrating this major milestone reflects the significant investments we have made in commercial operations, clinical education and training, and sales and marketing. At the same time, oral health and overall health conditions continue to be a challenge in certain regions across Latin America, especially in underserved areas. We are committed to making a difference in the communities where we work and live and we are inspired to be partnering with an organization like Por 1 Sorriso, that is dedicated to helping doctors improve the lives and smiles of people throughout Brazil.”

Data on file at Align Technology, Q1, 2021.


The Align Foundation


Launched in 2020, the Align Foundation provides a structured means by which significant donations are directed from a donor-advised fund overseen by Fidelity Charitable, with the flexibility to provide smaller monetary donations, processes to donate our products, as well as an organized way to involve our employees in giving activities. In March 2020, we funded $1 million to support COVID-19 relief efforts globally and donated personal protective equipment (PPE) such as N95 masks and worked with partners to source supplies for additional PPE to help hospitals and healthcare providers. To date, Align has contributed over $4.6 million to charitable causes including Operation Smile, America’s Toothfairy, and other non-profits dedicated to youth development through schools and educational programs. Over the last two years, our employees have volunteered over 10,000 hours as part of our dedicated month of giving in October called Month of Smiles.


Por1Sorriso


Por1Sorriso has been operating since 2015 with a focus on health and well-being through humanized dentistry and medicine, with actions in communities in situations of vulnerability and with little access to assistance, such as riverside and indigenous populations, residents of the Northeastern hinterland, populations in conditions of poverty on the African continent and urban communities. Volunteers include orthodontists, dentists, and doctors from other fields such as ultrasound, dermatology, gynecology, pediatrics. Por1Sorriso has assisted more than 15,000 people in Brazil and Africa.


About Align Technology, Inc.

Align Technology designs, manufactures and offers the Invisalign system, the most advanced clear aligner system in the world, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 200 thousand doctor customers and is key to accessing Align’s 500 million consumer market opportunity worldwide. Align has helped doctors treat over 10.2 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Forward-Looking Statements

This news release contains forward-looking statements, including quotations from management regarding the pace of Invisalign clear aligner adoption and the benefits and results or treatment, and the benefits of digital dentistry along with other statements and comments that are forward-looking. Forward-looking statements contained in this news release relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties, and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement.

Factors that might cause such a difference include, but are not limited to:

  • the impact of the COVID-19 pandemic on the health and safety of our employees, customers, patients, and our suppliers, as well as the physical and economic impacts of the various recommendations, orders, and protocols issued by local and national governmental agencies in light of continual evolution of the pandemic, including any periodic reimplementation of preventative measures in various global locations;
  • difficulties predicting customer and consumer purchasing behavior and changes in consumer spending habits as a result of, among other things, prevailing economic conditions, levels of employment, salaries and wages, and consumer confidence, particularly in light of the pandemic and as pandemic-related restrictions are eased regionally and globally;
  • unexpected or rapid changes in the growth or decline of our domestic and/or international markets;
  • increasing competition from existing and new competitors;
  • rapidly evolving and groundbreaking advances that fundamentally alter the dental industry or the way new and existing customers market and provide products and services to consumers;
  • the ability to protect our intellectual property rights;
  • continued compliance with regulatory requirements;
  • declines in, or the slowing of the growth of, sales of our intra-oral scanners domestically and/or internationally and the impact either would have on the adoption of Invisalign products;
  • the willingness and ability of our customers to maintain and/or increase product utilization in sufficient numbers;
  • the possibility that the development and release of new products or enhancements to existing products do not proceed in accordance with the anticipated timeline or may themselves contain bugs or errors requiring remediation and that the market for the sale of these new or enhanced products may not develop as expected;
  • a tougher consumer demand environment in China generally, especially for manufacturers and service providers whose headquarters or primarily operations are not based in China;
  • the risks relating to our ability to sustain or increase profitability or revenue growth in future periods (or minimize declines) while controlling expenses;
  • the impact of excess or constrained capacity at our manufacturing and treat operations facilities and pressure on our internal systems and personnel;
  • the compromise of customer and/or patient data for any reason;
  • the timing of case submissions from our doctors within a quarter as well as an increased manufacturing costs per case;
  • foreign operational, political and other risks relating to our international manufacturing operations; and
  • the loss of key personnel or work stoppages.

The foregoing and other risks are detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including, but not limited to, our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2021. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Align Technology

Madelyn Homick
(408) 470-1180
[email protected]
Zeno Group

Sarah Johnson
(828) 551-4201
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2f993ef1-97b0-4ebe-9e70-5629894175c9



Alerus Financial Corporation Reports First Quarter 2021 Net Income of $15.2 Million

Alerus Financial Corporation Reports First Quarter 2021 Net Income of $15.2 Million

GRAND FORKS, N.D.–(BUSINESS WIRE)–
Alerus Financial Corporation (Nasdaq: ALRS) reported net income of $15.2 million for the first quarter of 2021, or $0.86 per diluted common share, compared to net income of $10.2 million, or $0.57 per diluted common share, for the fourth quarter of 2020, and net income of $5.4 million, or $0.30 per diluted common share, for the first quarter of 2020.

CEO Comments

Chairman, President, and Chief Executive Officer Randy Newman said, “We are pleased to report our record performance of 2020 carried through into the first quarter of 2021. We believe Alerus continues to be well positioned for growth with our diversified business model, large and growing client base, and holistic, advisor-focused approach to serving clients. We started 2021 with several hiring initiatives and were pleased to have two high performing mortgage bankers join our Twin Cities team in the first quarter. We continue to focus on adding talent to our organization, especially in areas that will grow revenue.

Our fee income business lines delivered strong results lead by our mortgage division with mortgage originations exceeding $500 million for the quarter. Retirement and benefits revenue increased over 8% during the quarter as the integration of our recent acquisition of RPS/24HourFlex continues to perform as planned. Wealth management revenue grew almost 4% during the quarter as our advisors remained focused on proactive outreach to clients in our local footprint and nationwide.

On the banking side, we continued to see stable credit quality, strengthening local economies and low levels of loan deferrals during the quarter. Our reserve levels remain very robust at over 2% of loans (excluding Paycheck Protection Program, or PPP). In addition, we saw a modest uptick in commercial line utilization, solid loan demand, and building pipelines.

In addition to our emphases on growth, we are also focused on technology investments. Over the last several years, we have invested in new technology for both our business and consumer clients, and now, we continue to develop robotics and other automation processes to improve our efficiency and support our ongoing growth initiatives. Today, we have 26 automated process robots in production across our organization. Many of these robots were developed within the last year to support unprecedented mortgage volume and new loans under the PPP. Furthermore, we recently became one of 66 limited partners in a fund focused on the acceleration of technology for community banks. We believe this is a valued partnership that will allow us to stay abreast of emerging technology trends in the community banking landscape.

Also in the first quarter, we redeemed our previously issued subordinated debt with a rate of 5.75% and refinanced with subordinated debt issued to the Bank of North Dakota with an initial fixed annual rate of 3.50%. Our capital levels remain strong and we believe we have strong capital return potential with our proven ability to execute accretive M&A, our history of strong dividend yields, and our newly approved stock buyback plan. We believe our ability to execute a diversified business model in tandem with our strong financial foundation will maximize stockholder value long-term.”

Quarterly Highlights

  • Return on average total assets of 2.02%, compared to 1.34% for the fourth quarter of 2020
  • Return on average tangible common equity(1) of 23.03%, compared to 15.13% for the fourth quarter of 2020
  • Net interest margin (tax-equivalent)(1) was 3.12%, compared to 3.23% for the fourth quarter of 2020
  • Allowance for loan losses to total loans, excluding Paycheck Protection Program, or PPP, loans, was 2.01%, compared to 2.00% as of December 31, 2020
  • Efficiency ratio(1) of 66.43%, compared to 74.44% for the fourth quarter of 2020
  • Noninterest income increased $2.2 million and was 64.97% of total revenue, compared to 62.57% for the fourth quarter of 2020
  • Mortgage originations totaled $518.0 million, a 14.7% decrease from the fourth quarter of 2020
  • Investment securities increased $202.8 million, or 34.2%, from the fourth quarter of 2020
  • Loans held for sale decreased $43.8 million, or 35.8%, from the fourth quarter of 2020
  • Loans held for investment decreased $42.0 million, or 2.1%, from the fourth quarter of 2020
  • Deposits increased $145.6 million, or 5.7%, from the fourth quarter of 2020

(1) Represents a non-GAAP financial measure. See “Non-GAAP to GAAP Reconciliations and Calculation of Non-GAAP Financial Measures.”

Selected Financial Data (unaudited)

 

 

 

 

 

 

 

 

 

 

 

As of and for the

 

 

Three months ended

 

 

March 31,

 

December 31,

 

March 31,

(dollars and shares in thousands, except per share data)

 

2021

 

2020

 

2020

Performance Ratios

 

 

 

 

 

 

 

 

 

Return on average total assets

 

 

2.02

%

 

 

1.34

%

 

 

0.89

%

Return on average common equity

 

 

18.46

%

 

 

12.30

%

 

 

7.32

%

Return on average tangible common equity (1)

 

 

23.03

%

 

 

15.13

%

 

 

9.76

%

Noninterest income as a % of revenue

 

 

64.97

%

 

 

62.57

%

 

 

59.07

%

Net interest margin (tax-equivalent) (1)

 

 

3.12

%

 

 

3.23

%

 

 

3.35

%

Efficiency ratio (1)

 

 

66.43

%

 

 

74.44

%

 

 

77.47

%

Net charge-offs/(recoveries) to average loans

 

 

0.10

%

 

 

(0.30

)%

 

 

(0.14

)%

Dividend payout ratio

 

 

17.44

%

 

 

26.32

%

 

 

50.00

%

Per Common Share

 

 

 

 

 

 

 

 

 

Earnings per common share – basic

 

$

0.87

 

 

$

0.58

 

 

$

0.31

 

Earnings per common share – diluted

 

$

0.86

 

 

$

0.57

 

 

$

0.30

 

Dividends declared per common share

 

$

0.15

 

 

$

0.15

 

 

$

0.15

 

Tangible book value per common share (1)

 

$

15.95

 

 

$

16.00

 

 

$

14.55

 

Average common shares outstanding – basic

 

 

17,145

 

 

 

17,122

 

 

 

17,070

 

Average common shares outstanding – diluted

 

 

17,465

 

 

 

17,450

 

 

 

17,405

 

Other Data

 

 

 

 

 

 

 

 

 

Retirement and benefit services assets under administration/management

 

$

34,774,650

 

 

$

34,199,954

 

 

$

27,718,026

 

Wealth management assets under administration/management

 

 

3,357,530

 

 

 

3,338,594

 

 

 

2,746,052

 

Mortgage originations

 

 

518,014

 

 

 

607,166

 

 

 

228,568

 

(1) Represents a non-GAAP financial measure. See “Non-GAAP to GAAP Reconciliations and Calculation of Non-GAAP Financial Measures.”

Results of Operations

Net Interest Income

Net interest income for the first quarter of 2021 was $22.0 million, a decrease of $1.1 million, or 4.8%, from $23.2 million for the fourth quarter of 2020, and an increase of $3.2 million, or 17.0%, from $18.8 million for the first quarter of 2020. The linked quarter decrease in net interest income was primarily driven by a $2.0 million decrease in interest income from loans, the largest component of which was an $854 thousand decrease on interest and loan fees recognized on PPP loans. During the first quarter of 2021, average interest earning assets increased $10.5 million, primarily due to increases of $113.2 million in investment securities and $20.3 million in interest-bearing deposits with banks, partially offset by decreases of $82.5 million in loans held for investment and $40.6 million in loans held for sale. The change in the balance sheet mix resulted in a 21 basis point decrease in the average earning asset yield. The cost of interest-bearing liabilities decreased 16 basis points from the fourth quarter of 2020 primarily due to continued downward repricing of time deposits. The balance in average long-term liabilities decreased $33.0 million due to the redemption of a $50.0 million subordinated note that was completed on January 29, 2021. On March 30, 2021, we issued a $50.0 million subordinated note to the Bank of North Dakota, and as a result we anticipate the average balance of long-term liabilities to increase in the second quarter of 2021.

Net interest margin (tax-equivalent), a non-GAAP financial measure, was 3.12% for the first quarter of 2021, an 11 basis point decrease from 3.23% for the fourth quarter of 2020, and a 23 basis point decrease from 3.35% in the first quarter of 2020. The linked quarter decrease was primarily due to lower yields on interest earning assets, partially offset by lower rates on interest-bearing liabilities. Excluding PPP loans, net interest margin was 2.95% for the first quarter of 2021, an 8 basis point decrease from 3.03% for the fourth quarter of 2020. The year over year decrease was primarily attributable to the historically low and flat yield curve and a more liquid balance sheet mix which resulted in a 81 basis point decrease in interest earning asset yields and compressed net interest margin.

Noninterest Income

Noninterest income for the first quarter of 2021 was $40.9 million, a $2.2 million, or 5.6%, increase from the fourth quarter of 2020. The increase was primarily driven by a $1.3 million increase in retirement and benefit services revenue, a $351 thousand increase in mortgage banking revenue, and a $219 thousand increase in other noninterest income. The increase in retirement and benefit services income was primarily driven by the revenue attributable to the acquisition of Retirement Planning Services, Inc. (doing business as RPS Plan Administrators and 24HourFlex). The increase in mortgage banking revenue was primarily a result of a $3.0 million increase in the change in fair market value of the secondary market hedge, partially offset by a 28 basis point decrease in the gain on sale margin.

Noninterest income for the first quarter of 2021 increased $13.7 million, or 50.4%, from $27.2 million in the first quarter of 2020. This increase was primarily due to a $12.1 million increase in mortgage banking revenue, as mortgage originations increased from $228.6 million in the first quarter of 2020 to $518.0 million in the first quarter of 2021, and a $1.6 million increase in the change in fair market value of the secondary market hedge.

Noninterest Expense

Noninterest expense for the first quarter of 2021 was $43.0 million, a decrease of $4.1 million, or 8.7%, compared to the fourth quarter of 2020. The decrease was primarily due to decreases of $2.8 million in compensation expense, $659 thousand in business services, software and technology expense, $506 thousand in other noninterest expense, and $458 thousand in mortgage and lending expenses, partially offset by an $851 thousand increase in employee taxes and benefits driven by seasonally higher payroll related taxes. The decrease in compensation expense was primarily due to a decrease in mortgage related compensation and incentives.

Noninterest expense for the first quarter of 2021 increased $6.3 million, or 17.2%, from $36.7 million in the first quarter of 2020. The increase was primarily attributable to increased compensation expense, employee taxes and benefits and mortgage and lending expenses, primarily as a result of the significant year over year increase in mortgage originations. Additional compensation expense and employee taxes and benefits also increased as a result of the acquisition of RPS.

Financial Condition

Total assets were $3.2 billion as of March 31, 2021, an increase of $138.0 million, or 4.6%, from December 31, 2020. The overall increase in total assets included increases of $202.8 million in available-for-sale investment securities and $17.3 million in cash and cash equivalents, partially offset by a $43.8 million decrease in loans held for sale and a $42.0 million decrease in loans held for investment.

Loans

Total loans were $1.94 billion as of March 31, 2021, a decrease of $42.0 million, or 2.1%, from December 31, 2020. The decrease was primarily due to a $13.8 million decrease in the commercial and industrial loan portfolio, as approximately $93.6 million of PPP loans were forgiven, and $83.4 million of new PPP loans were originated and funded. The consumer loan portfolio decreased $30.7 million from December 31, 2020, due to high levels of refinancing and our strategic exit from indirect lending.

The following table presents the composition of our loan portfolio as of the dates indicated:

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

September 30,

 

June 30,

 

March 31,

(dollars in thousands)

 

2021

 

2020

 

2020

 

2020

 

2020

Commercial

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and industrial (1)

 

$

678,029

 

$

691,858

 

$

789,036

 

$

794,204

 

$

502,637

Real estate construction

 

 

40,473

 

 

44,451

 

 

33,169

 

 

31,344

 

 

25,487

Commercial real estate

 

 

569,451

 

 

563,007

 

 

535,216

 

 

519,104

 

 

522,106

Total commercial

 

 

1,287,953

 

 

1,299,316

 

 

1,357,421

 

 

1,344,652

 

 

1,050,230

Consumer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential real estate first mortgage

 

 

454,958

 

 

463,370

 

 

469,050

 

 

456,737

 

 

457,895

Residential real estate junior lien

 

 

130,299

 

 

143,416

 

 

152,487

 

 

154,351

 

 

170,538

Other revolving and installment

 

 

64,135

 

 

73,273

 

 

79,461

 

 

78,457

 

 

79,614

Total consumer

 

 

649,392

 

 

680,059

 

 

700,998

 

 

689,545

 

 

708,047

Total loans

 

$

1,937,345

 

$

1,979,375

 

$

2,058,419

 

$

2,034,197

 

$

1,758,277

(1) Includes PPP loans of $256.8 million at March 31, 2021, $268.4 million at December 31, 2020, $348.9 million at September 30, 2020 and $347.3 million at June 30, 2020.

Deposits

Total deposits were $2.72 billion as of March 31, 2021, an increase of $145.6 million, or 5.7%, from December 31, 2020. Interest-bearing deposits increased $124.9 million while noninterest-bearing deposits increased $20.7 million. Key drivers of the increase included inflows from government stimulus programs and higher depositor balances due to the uncertain economic environment and volatile financial markets. The increase in interest-bearing deposits included increases of $55.6 million in interest-bearing demand deposits, a $58.1 million increase in money market accounts, a $7.6 million increase in savings accounts and a $3.6 million increase in time deposits. Although overall deposits increased, there was a $26.6 million decrease in synergistic deposits, primarily in the retirement and benefit services money market accounts. Excluding synergistic deposits, commercial transaction deposits increased $135.2 million, or 12.2%, while consumer transaction deposits increased $24.3 million, or 3.8%, since December 31, 2020. Noninterest-bearing deposits as a percentage of total deposits was 28.5% as of March 31, 2021 compared to 29.3% as of December 31, 2020.

The following table presents the composition of our deposit portfolio as of the dates indicated:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

September 30,

 

June 30,

 

March 31,

(dollars in thousands)

 

2021

 

2020

 

2020

 

2020

 

2020

Noninterest-bearing demand

 

$

775,434

 

$

754,716

 

$

693,450

 

$

700,892

 

$

608,559

Interest-bearing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing demand

 

 

674,466

 

 

618,900

 

 

590,366

 

 

579,840

 

 

477,752

Savings accounts

 

 

87,492

 

 

79,902

 

 

78,659

 

 

75,973

 

 

60,181

Money market savings

 

 

967,273

 

 

909,137

 

 

892,473

 

 

892,717

 

 

773,652

Time deposits

 

 

212,908

 

 

209,338

 

 

207,422

 

 

203,731

 

 

201,370

Total interest-bearing

 

 

1,942,139

 

 

1,817,277

 

 

1,768,920

 

 

1,752,261

 

 

1,512,955

Total deposits

 

$

2,717,573

 

$

2,571,993

 

$

2,462,370

 

$

2,453,153

 

$

2,121,514

Asset Quality

Total nonperforming assets were $4.9 million as of March 31, 2021, a decrease of $248 thousand, or 4.8%, from December 31, 2020. As of March 31, 2021, the allowance for loan losses was $33.8 million, or 1.74% of total loans, compared to $34.2 million, or 1.73% of total loans, as of December 31, 2020. Excluding PPP loans, the ratio of allowance for loan losses to total loans was 2.01% as of March 31, 2021, compared to 2.00% as of December 31, 2020.

The following table presents selected asset quality data as of and for the periods indicated:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of and for the three months ended

 

 

March 31,

 

December 31,

 

September 30,

 

June 30,

 

March 31,

(dollars in thousands)

 

2021

 

2020

 

2020

 

2020

 

2020

Nonaccrual loans

 

$

4,756

 

 

$

5,050

 

 

$

4,795

 

 

$

5,328

 

 

$

6,959

 

Accruing loans 90+ days past due

 

 

 

 

 

30

 

 

 

 

 

 

 

 

 

11

 

Total nonperforming loans

 

 

4,756

 

 

 

5,080

 

 

 

4,795

 

 

 

5,328

 

 

 

6,970

 

OREO and repossessed assets

 

 

139

 

 

 

63

 

 

 

10

 

 

 

26

 

 

 

209

 

Total nonperforming assets

 

$

4,895

 

 

$

5,143

 

 

$

4,805

 

 

$

5,354

 

 

$

7,179

 

Net charge-offs/(recoveries)

 

 

488

 

 

 

(1,509

)

 

 

(581

)

 

 

3,264

 

 

 

(595

)

Net charge-offs/(recoveries) to average loans

 

 

0.10

%

 

 

(0.30

)%

 

 

(0.11

)%

 

 

0.66

%

 

 

(0.14

)%

Nonperforming loans to total loans

 

 

0.25

%

 

 

0.26

%

 

 

0.23

%

 

 

0.26

%

 

 

0.40

%

Nonperforming assets to total assets

 

 

0.16

%

 

 

0.17

%

 

 

0.17

%

 

 

0.19

%

 

 

0.29

%

Allowance for loan losses to total loans

 

 

1.74

%

 

 

1.73

%

 

 

1.52

%

 

 

1.34

%

 

 

1.54

%

Allowance for loan losses to nonperforming loans

 

 

710

%

 

 

674

%

 

 

654

%

 

 

512

%

 

 

388

%

For the first quarter of 2021, we had net charge-offs of $488 thousand compared to net recoveries of $1.5 million for the fourth quarter of 2020 and $595 thousand for the first quarter of 2020. The net charge-offs for the first quarter of 2021 were primarily due to a $452 thousand charge-off related to one commercial real estate client. Management does not believe that this charge-off was a result of economic uncertainties in the current environment.

The provision for loan losses for the first quarter of 2021 was zero, a decrease of $1.4 million from the fourth quarter of 2020 and a decrease of $2.5 million from the first quarter of 2020. Management decided additional provisions were not necessary in the first quarter of 2021 as credit quality indicators remained strong and loan balances decreased.

The ratio of nonperforming loans to total loans at March 31, 2021 was 0.25%, and if PPP loans were excluded, this ratio would have been 0.28%. Nonperforming assets as a percentage of total assets was 0.16% at March 31, 2021. Excluding PPP loans, nonperforming assets as a percentage of total assets would have been 0.17% at March 31, 2021.

Beginning in 2020, in accordance with the Interagency Statement on Loan Modifications and Reporting for Financial Institutions as issued on April 7, 2020, through March 31, 2021, we had entered into principal and interest deferrals on 582 loans, representing $154.0 million in total outstanding principal balances. Of those loans, 16 loans with a total outstanding principal balance of $7.6 million have been granted additional deferrals, 6 loans with a total outstanding principal balance of $767 thousand remain on the first deferral and the remaining loans have been returned to normal payment status. These loan modifications are not considered troubled debt restructurings.

Capital

Total stockholders’ equity was $329.2 million as of March 31, 2021, a decrease of $929 thousand from December 31, 2020. The tangible book value per common share, a non-GAAP financial measure, decreased to $15.95 as of March 31, 2021, from $16.00 as of December 31, 2020. Tangible common equity to tangible assets, a non-GAAP financial measure, decreased to 8.86% as of March 31, 2021, from 9.27% as of December 31, 2020, primarily due to a $13.6 million decrease in accumulated other comprehensive income. The tangible common equity to tangible assets ratio, a non-GAAP financial measure, excluding PPP loans, was 9.66% as of March 31, 2021.

The following table presents our capital ratios as of the dates indicated:

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

March 31,

 

 

 

2021

 

2020

 

2020

 

Capital Ratios(1)

 

 

 

 

 

 

 

 

 

 

Alerus Financial Corporation Consolidated

 

 

 

 

 

 

 

 

 

 

Common equity tier 1 capital to risk weighted assets

 

 

13.48

%

 

12.75

%

 

12.36

%

Tier 1 capital to risk weighted assets

 

 

13.88

%

 

13.15

%

 

12.78

%

Total capital to risk weighted assets

 

 

17.54

%

 

16.79

%

 

16.55

%

Tier 1 capital to average assets

 

 

9.59

%

 

9.24

%

 

10.62

%

Tangible common equity / tangible assets (2)

 

 

8.86

%

 

9.27

%

 

10.09

%

 

 

 

 

 

 

 

 

 

 

 

Alerus Financial, N.A.

 

 

 

 

 

 

 

 

 

 

Common equity tier 1 capital to risk weighted assets

 

 

12.80

%

 

12.10

%

 

11.80

%

Tier 1 capital to risk weighted assets

 

 

12.80

%

 

12.10

%

 

11.80

%

Total capital to risk weighted assets

 

 

14.06

%

 

13.36

%

 

13.05

%

Tier 1 capital to average assets

 

 

8.85

%

 

8.50

%

 

9.80

%

(1) Capital ratios for the current quarter are to be considered preliminary until the Call Report for Alerus Financial, N.A. is filed.

(2) Represents a non-GAAP financial measure. See “Non-GAAP to GAAP Reconciliations and Calculation of Non-GAAP Financial Measures.”

Conference Call

The Company will host a conference call at 9:00 a.m. Central Time on Thursday, April 29, 2021, to discuss its financial results. The call can be accessed via telephone at (888) 317-6016. A recording of the call and transcript will be available on the Company’s investor relations website at investors.alerus.com following the call.

About Alerus Financial Corporation

Alerus Financial Corporation is a diversified financial services company headquartered in Grand Forks, ND. Through its subsidiary, Alerus Financial, N.A., Alerus provides innovative and comprehensive financial solutions to business and consumer clients through four distinct business segments—banking, retirement and benefit services, wealth management, and mortgage. Alerus provides clients with a primary point of contact to help fully understand the unique needs and delivery channel preferences of each client. Clients are provided with competitive products, valuable insight and sound advice supported by digital solutions designed to meet the clients’ needs. Alerus Financial banking and wealth management offices are located in Grand Forks and Fargo, ND, the Minneapolis-St. Paul, MN metropolitan area, and Scottsdale and Mesa, AZ. Alerus Retirement and Benefits plan administration offices are located in St. Paul, MN, East Lansing, MI, and Littleton, CO.

Non-GAAP Financial Measures

Some of the financial measures included in this press release are not measures of financial performance recognized by U.S. Generally Accepted Accounting Principles, or GAAP. These non-GAAP financial measures include the ratio of tangible common equity to tangible assets, tangible common equity per share, return on average tangible common equity, net interest margin (tax-equivalent), and the efficiency ratio. Management uses these non-GAAP financial measures in its analysis of its performance, and believes financial analysts and investors frequently use these measures, and other similar measures, to evaluate capital adequacy. Reconciliations of non-GAAP disclosures used in this press release to the comparable GAAP measures are provided in the accompanying tables. Management, banking regulators, many financial analysts and other investors use these measures in conjunction with more traditional bank capital ratios to compare the capital adequacy of banking organizations with significant amounts of goodwill or other intangible assets, which typically stem from the use of the purchase accounting method of accounting for mergers and acquisitions.

These non-GAAP financial measures should not be considered in isolation or as a substitute for total stockholders’ equity, total assets, book value per share, return on average assets, return on average equity, or any other measure calculated in accordance with GAAP. Moreover, the manner in which we calculate these non-GAAP financial measures may differ from that of other companies reporting measures with similar names.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements concerning plans, estimates, calculations, forecasts and projections with respect to the anticipated future performance of Alerus Financial Corporation. These statements are often, but not always, identified by words such as “may”, “might”, “should”, “could”, “predict”, “potential”, “believe”, “expect”, “continue”, “will”, “anticipate”, “seek”, “estimate”, “intend”, “plan”, “projection”, “would”, “annualized”, “target” and “outlook”, or the negative version of those words or other comparable words of a future or forward-looking nature. Examples of forward-looking statements include, among others, statements we make regarding our projected growth, anticipated future financial performance, financial condition, credit quality, management’s long-term performance goals and the future plans and prospects of Alerus Financial Corporation.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the effects of the COVID-19 pandemic, including its effects on the economic environment, our clients, and our operations, as well as any changes to federal, state, or local government laws, regulations, or orders in response to the pandemic; our ability to successfully manage credit risk and maintain an adequate level of allowance for loan losses; new or revised accounting standards, including as a result of the implementation of the new Current Expected Credit Loss Standard; business and economic conditions generally and in the financial services industry, nationally and within our market areas; the overall health of the local and national real estate market; concentrations within our loan portfolio; the level of nonperforming assets on our balance sheet; our ability to implement our organic and acquisition growth strategies; the impact of economic or market conditions on our fee-based services; our ability to continue to grow our retirement and benefit services business; our ability to continue to originate a sufficient volume of residential mortgages; the occurrence of fraudulent activity, breaches or failures of our information security controls or cybersecurity-related incidents; interruptions involving our information technology and telecommunications systems or third-party servicers; potential losses incurred in connection with mortgage loan repurchases; the composition of our executive management team and our ability to attract and retain key personnel; rapid technological change in the financial services industry; increased competition in the financial services industry; our ability to successfully manage liquidity risk; the effectiveness of our risk management framework; the commencement and outcome of litigation and other legal proceedings and regulatory actions against us or to which we may become subject; potential impairment to the goodwill we recorded in connection with our past acquisitions; the extensive regulatory framework that applies to us; the impact of recent and future legislative and regulatory changes; interest rate risks associated with our business; fluctuations in the values of the securities held in our securities portfolio; governmental monetary, trade and fiscal policies; severe weather, natural disasters, widespread disease or pandemics, such as the COVID-19 global pandemic, acts of war or terrorism or other adverse external events; any material weaknesses in our internal control over financial reporting; developments and uncertainty related to the future use and availability of some reference rates, such as the London Interbank Offered Rate, as well as other alternative rates; changes to U.S. tax laws, regulations and guidance; our success at managing the risks involved in the foregoing items; and any other risks described in the “Risk Factors” sections of the reports filed by Alerus Financial Corporation with the Securities and Exchange Commission.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Alerus Financial Corporation and Subsidiaries

Consolidated Balance Sheets

(dollars and shares in thousands, except per share data)

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

 

2021

 

2020

Assets

 

(Unaudited)

 

(Audited)

Cash and cash equivalents

 

$

190,217

 

 

$

172,962

 

Investment securities, at fair value

 

 

 

 

 

 

Available-for-sale

 

 

795,097

 

 

 

592,342

 

Loans held for sale

 

 

78,665

 

 

 

122,440

 

Loans

 

 

1,937,345

 

 

 

1,979,375

 

Allowance for loan losses

 

 

(33,758

)

 

 

(34,246

)

Net loans

 

 

1,903,587

 

 

 

1,945,129

 

Land, premises and equipment, net

 

 

19,605

 

 

 

20,289

 

Operating lease right-of-use assets

 

 

6,293

 

 

 

6,918

 

Accrued interest receivable

 

 

9,271

 

 

 

9,662

 

Bank-owned life insurance

 

 

32,556

 

 

 

32,363

 

Goodwill

 

 

30,201

 

 

 

30,201

 

Other intangible assets

 

 

24,768

 

 

 

25,919

 

Servicing rights

 

 

1,952

 

 

 

1,987

 

Deferred income taxes, net

 

 

13,700

 

 

 

9,409

 

Other assets

 

 

45,844

 

 

 

44,150

 

Total assets

 

$

3,151,756

 

 

$

3,013,771

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Deposits

 

 

 

 

 

 

Noninterest-bearing

 

$

775,434

 

 

$

754,716

 

Interest-bearing

 

 

1,942,139

 

 

 

1,817,277

 

Total deposits

 

 

2,717,573

 

 

 

2,571,993

 

Long-term debt

 

 

59,020

 

 

 

58,735

 

Operating lease liabilities

 

 

7,140

 

 

 

7,861

 

Accrued expenses and other liabilities

 

 

38,789

 

 

 

45,019

 

Total liabilities

 

 

2,822,522

 

 

 

2,683,608

 

Stockholders’ equity

 

 

 

 

 

 

Preferred stock, $1 par value, 2,000,000 shares authorized: 0 issued and outstanding

 

 

 

 

 

 

Common stock, $1 par value, 30,000,000 shares authorized: 17,190,481 and 17,125,270 issued and outstanding

 

 

17,190

 

 

 

17,125

 

Additional paid-in capital

 

 

90,520

 

 

 

90,237

 

Retained earnings

 

 

224,480

 

 

 

212,163

 

Accumulated other comprehensive income (loss)

 

 

(2,956

)

 

 

10,638

 

Total stockholders’ equity

 

 

329,234

 

 

 

330,163

 

Total liabilities and stockholders’ equity

 

$

3,151,756

 

 

$

3,013,771

 

Alerus Financial Corporation and Subsidiaries

Consolidated Statements of Income

(dollars and shares in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

March 31,

 

December 31,

 

March 31,

 

 

2021

 

2020

 

2020

Interest Income

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

Loans, including fees

 

$

20,567

 

$

22,549

 

$

20,542

Investment securities

 

 

 

 

 

 

 

 

 

Taxable

 

 

2,401

 

 

2,301

 

 

1,759

Exempt from federal income taxes

 

 

236

 

 

237

 

 

235

Other

 

 

117

 

 

114

 

 

570

Total interest income

 

 

23,321

 

 

25,201

 

 

23,106

Interest Expense

 

 

 

 

 

 

 

 

 

Deposits

 

 

995

 

 

1,210

 

 

3,392

Long-term debt

 

 

288

 

 

838

 

 

877

Total interest expense

 

 

1,283

 

 

2,048

 

 

4,269

Net interest income

 

 

22,038

 

 

23,153

 

 

18,837

Provision for loan losses

 

 

 

 

1,400

 

 

2,500

Net interest income after provision for loan losses

 

 

22,038

 

 

21,753

 

 

16,337

Noninterest Income

 

 

 

 

 

 

 

 

 

Retirement and benefit services

 

 

17,255

 

 

15,922

 

 

16,220

Wealth management

 

 

4,986

 

 

4,807

 

 

4,046

Mortgage banking

 

 

17,132

 

 

16,781

 

 

5,045

Service charges on deposit accounts

 

 

338

 

 

334

 

 

423

Net gains (losses) on investment securities

 

 

114

 

 

15

 

 

Other

 

 

1,056

 

 

837

 

 

1,455

Total noninterest income

 

 

40,881

 

 

38,696

 

 

27,189

Noninterest Expense

 

 

 

 

 

 

 

 

 

Compensation

 

 

23,698

 

 

26,522

 

 

18,731

Employee taxes and benefits

 

 

5,813

 

 

4,962

 

 

5,308

Occupancy and equipment expense

 

 

2,231

 

 

2,443

 

 

2,492

Business services, software and technology expense

 

 

4,976

 

 

5,635

 

 

4,543

Intangible amortization expense

 

 

1,151

 

 

990

 

 

990

Professional fees and assessments

 

 

1,472

 

 

1,531

 

 

1,056

Marketing and business development

 

 

676

 

 

1,045

 

 

610

Supplies and postage

 

 

531

 

 

544

 

 

707

Travel

 

 

26

 

 

21

 

 

261

Mortgage and lending expenses

 

 

1,332

 

 

1,790

 

 

1,141

Other

 

 

1,136

 

 

1,642

 

 

887

Total noninterest expense

 

 

43,042

 

 

47,125

 

 

36,726

Income before income taxes

 

 

19,877

 

 

13,324

 

 

6,800

Income tax expense

 

 

4,662

 

 

3,144

 

 

1,437

Net income

 

$

15,215

 

$

10,180

 

$

5,363

Per Common Share Data

 

 

 

 

 

 

 

 

 

Earnings per common share

 

$

0.87

 

$

0.58

 

$

0.31

Diluted earnings per common share

 

$

0.86

 

$

0.57

 

$

0.30

Dividends declared per common share

 

$

0.15

 

$

0.15

 

$

0.15

Average common shares outstanding

 

 

17,145

 

 

17,122

 

 

17,070

Diluted average common shares outstanding

 

 

17,465

 

 

17,450

 

 

17,405

Alerus Financial Corporation and Subsidiaries

Non-GAAP to GAAP Reconciliations and Calculation of Non-GAAP Financial Measures (unaudited)

(dollars and shares in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

March 31,

 

 

2021

 

2020

 

2020

Tangible Common Equity to Tangible Assets

 

 

 

 

 

 

 

 

 

Total common stockholders’ equity

 

$

329,234

 

 

$

330,163

 

 

$

293,608

 

Less: Goodwill

 

 

30,201

 

 

 

30,201

 

 

 

27,329

 

Less: Other intangible assets

 

 

24,768

 

 

 

25,919

 

 

 

17,401

 

Tangible common equity (a)

 

 

274,265

 

 

 

274,043

 

 

 

248,878

 

Total assets

 

 

3,151,756

 

 

 

3,013,771

 

 

 

2,512,078

 

Less: Goodwill

 

 

30,201

 

 

 

30,201

 

 

 

27,329

 

Less: Other intangible assets

 

 

24,768

 

 

 

25,919

 

 

 

17,401

 

Tangible assets (b)

 

 

3,096,787

 

 

 

2,957,651

 

 

 

2,467,348

 

Tangible common equity to tangible assets (a)/(b)

 

 

8.86

%

 

 

9.27

%

 

 

10.09

%

Tangible Book Value Per Common Share

 

 

 

 

 

 

 

 

 

Total common stockholders’ equity

 

$

329,234

 

 

$

330,163

 

 

$

293,608

 

Less: Goodwill

 

 

30,201

 

 

 

30,201

 

 

 

27,329

 

Less: Other intangible assets

 

 

24,768

 

 

 

25,919

 

 

 

17,401

 

Tangible common equity (c)

 

 

274,265

 

 

 

274,043

 

 

 

248,878

 

Total common shares issued and outstanding (d)

 

 

17,190

 

 

 

17,125

 

 

 

17,106

 

Tangible book value per common share (c)/(d)

 

$

15.95

 

 

$

16.00

 

 

$

14.55

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

March 31,

 

December 31,

 

March 31,

 

 

2021

 

2020

 

2020

Return on Average Tangible Common Equity

 

 

 

 

 

 

 

 

 

Net income

 

$

15,215

 

 

$

10,180

 

 

$

5,363

 

Add: Intangible amortization expense (net of tax)

 

 

909

 

 

 

782

 

 

 

782

 

Net income, excluding intangible amortization (e)

 

 

16,124

 

 

 

10,962

 

 

 

6,145

 

Average total equity

 

 

334,188

 

 

 

329,210

 

 

 

294,727

 

Less: Average goodwill

 

 

30,201

 

 

 

27,766

 

 

 

27,329

 

Less: Average other intangible assets (net of tax)

 

 

19,995

 

 

 

13,206

 

 

 

14,128

 

Average tangible common equity (f)

 

 

283,992

 

 

 

288,238

 

 

 

253,270

 

Return on average tangible common equity (e)/(f)

 

 

23.03

%

 

 

15.13

%

 

 

9.76

%

Net Interest Margin (tax-equivalent)

 

 

 

 

 

 

 

 

 

Net interest income

 

$

22,038

 

 

$

23,153

 

 

$

18,837

 

Tax-equivalent adjustment

 

 

143

 

 

 

131

 

 

 

100

 

Tax-equivalent net interest income (g)

 

 

22,181

 

 

 

23,284

 

 

 

18,937

 

Average earning assets (h)

 

 

2,880,255

 

 

 

2,869,767

 

 

 

2,271,004

 

Net interest margin (tax-equivalent) (g)/(h)

 

 

3.12

%

 

 

3.23

%

 

 

3.35

%

Efficiency Ratio

 

 

 

 

 

 

 

 

 

Noninterest expense

 

$

43,042

 

 

$

47,125

 

 

$

36,726

 

Less: Intangible amortization expense

 

 

1,151

 

 

 

990

 

 

 

990

 

Adjusted noninterest expense (i)

 

 

41,891

 

 

 

46,135

 

 

 

35,736

 

Net interest income

 

 

22,038

 

 

 

23,153

 

 

 

18,837

 

Noninterest income

 

 

40,881

 

 

 

38,696

 

 

 

27,189

 

Tax-equivalent adjustment

 

 

143

 

 

 

131

 

 

 

100

 

Total tax-equivalent revenue (j)

 

 

63,062

 

 

 

61,980

 

 

 

46,126

 

Efficiency ratio (i)/(j)

 

 

66.43

%

 

 

74.44

%

 

 

77.47

%

Alerus Financial Corporation and Subsidiaries

Analysis of Average Balances, Yields, and Rates (unaudited)

(dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

March 31, 2021

 

December 31, 2020

 

March 31, 2020

 

 

 

 

 

Average

 

 

 

 

Average

 

 

 

 

Average

 

 

Average

 

Yield/

 

Average

 

Yield/

 

Average

 

Yield/

 

 

Balance

 

Rate

 

Balance

 

Rate

 

Balance

 

Rate

Interest Earning Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing deposits with banks

 

$

184,376

 

0.12

%

 

$

164,052

 

0.12

%

 

$

163,351

 

1.24

%

Investment securities (1)

 

 

662,413

 

1.65

%

 

 

549,198

 

1.88

%

 

 

337,160

 

2.45

%

Loans held for sale

 

 

82,249

 

2.13

%

 

 

122,820

 

2.18

%

 

 

33,138

 

3.08

%

Loans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial and industrial

 

 

674,935

 

4.72

%

 

 

745,415

 

4.91

%

 

 

479,291

 

5.26

%

Real estate construction

 

 

45,264

 

4.22

%

 

 

40,009

 

4.31

%

 

 

26,723

 

5.03

%

Commercial real estate

 

 

560,986

 

3.79

%

 

 

545,432

 

3.82

%

 

 

508,164

 

4.61

%

Total commercial

 

 

1,281,185

 

4.30

%

 

 

1,330,856

 

4.45

%

 

 

1,014,178

 

4.93

%

Consumer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential real estate first mortgage

 

 

457,882

 

3.76

%

 

 

471,125

 

3.73

%

 

 

460,726

 

4.10

%

Residential real estate junior lien

 

 

137,745

 

4.86

%

 

 

149,456

 

4.72

%

 

 

173,436

 

5.17

%

Other revolving and installment

 

 

68,625

 

4.38

%

 

 

76,466

 

4.53

%

 

 

83,253

 

4.69

%

Total consumer

 

 

664,252

 

4.05

%

 

 

697,047

 

4.03

%

 

 

717,415

 

4.43

%

Total loans (1)

 

 

1,945,437

 

4.21

%

 

 

2,027,903

 

4.30

%

 

 

1,731,593

 

4.72

%

Federal Reserve/FHLB stock

 

 

5,780

 

4.49

%

 

 

5,794

 

4.46

%

 

 

5,762

 

4.75

%

Total interest earning assets

 

 

2,880,255

 

3.30

%

 

 

2,869,767

 

3.51

%

 

 

2,271,004

 

4.11

%

Noninterest earning assets

 

 

167,006

 

 

 

 

158,417

 

 

 

 

148,661

 

 

Total assets

 

$

3,047,261

 

 

 

$

3,028,184

 

 

 

$

2,419,665

 

 

Interest-Bearing Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing demand deposits

 

$

642,832

 

0.16

%

 

$

622,854

 

0.19

%

 

$

459,028

 

0.46

%

Money market and savings deposits

 

 

1,030,348

 

0.16

%

 

 

1,012,497

 

0.20

%

 

 

803,838

 

1.04

%

Time deposits

 

 

210,719

 

0.66

%

 

 

208,378

 

0.79

%

 

 

199,088

 

1.59

%

Long-term debt

 

 

25,677

 

4.55

%

 

 

58,726

 

5.68

%

 

 

58,755

 

6.00

%

Total interest-bearing liabilities

 

 

1,909,576

 

0.27

%

 

 

1,902,455

 

0.43

%

 

 

1,520,709

 

1.13

%

Noninterest-Bearing Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Noninterest-bearing deposits

 

 

731,680

 

 

 

 

738,319

 

 

 

 

564,307

 

 

Other noninterest-bearing liabilities

 

 

71,817

 

 

 

 

58,200

 

 

 

 

39,922

 

 

Stockholders’ equity

 

 

334,188

 

 

 

 

329,210

 

 

 

 

294,727

 

 

Total liabilities and stockholders’ equity

 

$

3,047,261

 

 

 

$

3,028,184

 

 

 

$

2,419,665

 

 

Net interest rate spread

 

 

 

 

3.03

%

 

 

 

 

3.08

%

 

 

 

 

2.98

%

Net interest margin, tax-equivalent (2)

 

 

 

 

3.12

%

 

 

 

 

3.23

%

 

 

 

 

3.35

%

(1) Taxable-equivalent adjustment was calculated utilizing a marginal income tax rate of 21.0%.

(2) Represents a non-GAAP financial measure. See “Non-GAAP to GAAP Reconciliations and Calculation of Non-GAAP Financial Measures.

Katie A. Lorenson, Chief Financial Officer

952.417.3725 (Office)

KEYWORDS: United States North America North Dakota Minnesota

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

First Northwest Bancorp Earns $3.1 Million, or $0.34 Per Diluted Share, in First Quarter 2021; Highlighted by Net Interest Margin Expansion and Strong Asset Quality; Declares Quarterly Cash Dividend of $0.06 Per Share

PORT ANGELES, Wash., April 28, 2021 (GLOBE NEWSWIRE) — First Northwest Bancorp (Nasdaq: FNWB) (“Company”), the holding company for First Federal Savings and Loan Association of Port Angeles (“Bank” or “First Fed”), today reported that net income increased 257.6% to $3.1 million, or $0.34 per diluted share, for the first quarter of 2021, compared to $873,000, or $0.09 per diluted share, for the first quarter a year ago, and decreased compared to net income of $3.8 million, or $0.41 per diluted share, for the fourth quarter of 2020. First quarter results reflected strong year-over-year revenue growth, core deposit growth and net interest margin expansion. The decrease from the prior period was primarily due to lower gains on sale of one-to-four family mortgages and available for sale investments, partially offset by increased net interest income and a lower provision for loan losses. The Company also announced that its Board of Directors declared a regular quarterly cash dividend of $0.06 per common share outstanding, payable on May 28, 2021 to shareholders of record as of the close of business on May 14, 2021.

“First Northwest Bancorp’s first quarter operating results were highlighted by strong revenue generation fueled by solid net interest income and core deposit growth,” stated Matthew P. Deines, President and CEO. “Despite ongoing pressures on loan and investment yields, net interest income increased $4.1 million, or 43.3%, over the first quarter of 2020, boosted by growth in earning assets, $362,000 in Paycheck Protection Program (“PPP”) income and a significant decline in cost of funds. We continue to generate organic commercial and consumer activity as we support our communities through an emerging recovery.”

“We are actively participating in the SBA’s current round of PPP funding that began in January 2021 and concludes at the end of May,” said Deines. “This round of SBA funding offers PPP loans for companies that did not receive a PPP loan in 2020, and also “second draw” loans targeted at hard-hit businesses that have already used their initial PPP proceeds. We funded $32.4 million in second round PPP loans during the first quarter of 2021.”

First Quarter 2021 Highlights (at or for the quarter ended March 31, 2021)

  • First quarter net income was $3.1 million, compared to $3.8 million in the preceding quarter and $873,000 in the year ago quarter.
  • Diluted earnings per share was $0.34, compared to $0.41 per share in the preceding quarter and $0.09 per share in the first quarter a year ago.
  • Provision for loan losses was $500,000 in the first quarter, compared to $930,000 in the fourth quarter of 2020 and $1.3 million in the first quarter of 2020.
  • Loans receivable increased 1.3% to $1.16 billion at March 31, 2021, compared to $1.14 billion at December 31, 2020, and increased 28.6% compared to $899.2 million a year ago, primarily due to growth in commercial real estate and commercial business loans, including PPP loans.
  • Deposits increased 7.6% during the quarter and increased 34.9% from one year prior, to $1.43 billion at March 31, 2021, due to successful organic and wholesale deposit-gathering strategies, including significant growth in noninterest-bearing deposits, which increased 76.8% in the last twelve months. Deposit balances benefitted from a second round of PPP and additional Federal stimulus payments during the quarter.
  • The cost of deposits for the first quarter decreased to 0.27% from 0.33% for fourth quarter 2020 and 0.85% in the first quarter of 2020.
  • Gain on sale of mortgage loans was $1.3 million for the first quarter compared to $2.3 million in the previous quarter and $383,000 in the first quarter of 2020, reflecting a modest slowdown in activity from the fourth quarter of 2020 and strong year-over-year quarterly mortgage originations, including refinance activity.
  • During the first quarter, the Company repurchased 135,837 shares of common stock at an average price of $15.89 per share for a total of $2.2 million, leaving 872,030 shares remaining under the 2020 Stock Repurchase Plan approved in October 2020.

Recent Developments

On March 22, 2021 the Company announced that First Fed has entered into an agreement with Sterling Bank and Trust of Southfield, Michigan to purchase its Bellevue, Washington branch, subject to applicable regulatory approvals and other customary closing conditions. The agreement includes the purchase of approximately $77.7 million in deposits as of the announcement date. First Fed expects to close the transaction by the end of the second quarter of 2021.

On April 16, 2021, the Company issued 29,719 shares of the Company’s common stock under the terms of an Amended and Restated Joint Venture Agreement dated April 15, 2021 (the “Joint Venture Agreement”) with the Bank, POM Peace of Mind, Inc. (“POM”), and Quin Ventures, Inc. (“Quin”). The shares were issued to POM and had a value of approximately $500,000. Under the Joint Venture Agreement, the Company and POM have established Quin to develop a digital financial wellness platform that will offer personal financial services to the general public. Under a related Marketing and Banking Services Agreement, Quin will promote the services offered through the digital financial wellness platform and the Bank will provide banking services to the customers who utilize the platform. The Marketing and Banking Services Agreement sets forth the terms governing the parties’ commercial and economic commitments and responsibilities, including the fees to be paid by the Bank to fund the costs of acquiring customers and the distribution of interchange fees. The Company has also committed to extend $15.0 million to Quin under a capital financing agreement and related promissory note.

Balance Sheet Review

Total assets increased $81.9 million, or 5.0%, to $1.74 billion at March 31, 2021, compared to $1.65 billion at December 31, 2020, and increased $339.4 million, or 24.3%, compared to $1.40 billion at March 31, 2020.

Cash and cash equivalents increased by $34.1 million, or 52.4%, to $99.3 million as of March 31, 2021, compared to $65.2 million as of December 31, 2020, as the result of gross proceeds of $40.0 million from the issuance of subordinated debt as well an increase in deposits of $101.3 million offset by increases to investment securities and loans receivable.

Investment securities increased $29.2 million to $393.5 million at March 31, 2021, compared to $364.3 million three months earlier, and increased $76.0 million compared to $317.5 million at March 31, 2020. At March 31, 2021, municipal bonds totaled $132.5 million and comprised the largest portion of the investment portfolio at 33.7%. The estimated average life of the total investment securities portfolio was 7.5 years, and the average repricing term was approximately 5.3 years.

“We continue to utilize the investment portfolio as a means to generate additional interest income,” said Geri Bullard, EVP/Chief Financial Officer. “We began adding to the investment portfolio a year ago as credit spreads widened, to deploy excess cash and prudently manage the balance sheet.”

Securities consisted of the following at the dates indicated:

    March 31,
2021
    December 31,
2020
    March 31,
2020
    Three
Month
Change
    One Year
Change
 
       
    (In thousands)  
Available for Sale at Fair Value                                        
Municipal bonds   $ 132,492     $ 127,862     $ 52,254     $ 4,630     $ 80,238  
U.S. government and agency issued bonds (Agency bonds)     1,913                   1,913       1,913  
U.S. government agency issued asset-backed securities (ABS agency)     65,910       63,820       42,125       2,090       23,785  
Corporate issued asset-backed securities (ABS corporate)     17,505       29,280       34,073       (11,775 )     (16,568 )
Corporate issued debt securities (Corporate debt)     43,890       35,510       9,439       8,380       34,451  
U.S. Small Business Administration securities (SBA)     17,566       18,564       25,363       (998 )     (7,797 )
Mortgage-backed securities:                                        
U.S. government agency issued mortgage-backed securities (MBS agency)     74,016       62,683       145,139       11,333       (71,123 )
Corporate issued mortgage-backed securities (MBS corporate)     40,203       26,577       9,127       13,626       31,076  
Total securities available for sale   $ 393,495     $ 364,296     $ 317,520     $ 29,199     $ 75,975  

Net loans, excluding loans held for sale, increased $14.5 million, or 1.3%, to $1.16 billion at March 31, 2021, from $1.14 billion at December 31, 2020, and increased $257.3 million, or 28.6%, from $899.2 million a year ago. “Our lending team did an excellent job growing the loan portfolio despite a competitive operating environment, with total loans increasing 28.6% over the last twelve months,” said Randy Riffle, EVP/Chief Lending Officer. “Additionally, new PPP loan production from the SBA’s latest round contributed meaningfully to loan production, with $32.4 million in new PPP loans funded during the first quarter.” Commercial business loans decreased $17.2 million during the quarter as the result of a decrease of $41.6 million in the Northpointe Mortgage Participation program offset by an increase of $24.7 in PPP loans.

The Company originated $66.3 million in residential mortgages during the quarter and sold $37.0 million, with an average gross margin on sale of mortgage loans of approximately 2.85%. This production compares to residential mortgage originations of $95.7 million in the preceding quarter with sales of $59.3 million, with an average gross margin of 3.01%. “Mortgage banking activity exceeded the first quarter of 2020, bucking seasonal trends, especially for refinances of existing mortgages as interest rates remain historically low,” said Kelly Liske, Chief Banking Officer.

Loans receivable consisted of the following at the dates indicated:

    March 31,
2021
    December 31,
2020
    March 31,
2020
    Three
Month
Change
    One Year
Change
 
       
    (In thousands)  
Real Estate:                                        
One to four family   $ 295,831     $ 309,828     $ 302,688     $ (13,997 )   $ (6,857 )
Multi-family     162,487       162,467       88,794       20       73,693  
Commercial real estate     296,826       296,574       260,321       252       36,505  
Construction and land     157,316       123,627       48,565       33,689       108,751  
Total real estate loans     912,460       892,496       700,368       19,964       212,092  
                                         
Consumer:                                        
Home equity     33,713       33,103       35,260       610       (1,547 )
Auto and other consumer     139,134       128,233       114,194       10,901       24,940  
Total consumer loans     172,847       161,336       149,454       11,511       23,393  
                                         
Commercial business     83,033       100,201       55,853       (17,168 )     27,180  
                                         
Total loans     1,168,340       1,154,033       905,675       14,307       262,665  
Less:                                        
Net deferred loan fees     4,983       4,346       433       637       4,550  
Premium on purchased loans, net     (7,347 )     (6,129 )     (4,742 )     (1,218 )     (2,605 )
Allowance for loan losses     14,265       13,847       10,830       418       3,435  
Total loans receivable, net   $ 1,156,439     $ 1,141,969     $ 899,154     $ 14,470     $ 257,285  

The sectors most heavily impacted by the pandemic include hospitality; restaurant and food services; and lessors of commercial real estate to these businesses. The table below presents selected information on loans to these industries as of March 31, 2021.

Industry % of Total
Loan
Portfolio
  Loan Balance   Number
of Loans
  Average
Loan-to-Value
      (In thousands)          
Hospitality 4.4 %   $50,332     14     60.6 %
Restaurant and food services 0.2     1,907     6     64.8  
Lessors of commercial real estate to hospitality, restaurant, and retail establishments 4.3     48,103     27     52.3  

The table below presents selected information on loans that remained on COVID-19 deferrals at the periods indicated.

  % of Total
Loan Portfolio
  Deferred Loan
Balance
  Number
of Loans
      (In thousands)      
June 30, 2020 12.9 %   $128,420     297  
September 30, 2020 13.9     149,542     183  
December 31, 2020 0.2     2,349     19  
March 31, 2021 0.7     8,052     4  

Total deposits increased $101.3 million, or 7.6%, to $1.43 billion at March 31, 2021, compared to $1.33 billion at December 31, 2020, and increased $370.9 million, or 34.9%, when compared to $1.06 billion a year ago. Savings accounts increased 12.3% compared to a year ago to $186.2 million at March 31, 2021, and represented 13.0% of total deposits; transaction accounts increased 62.8% compared to a year ago to $466.1 million at March 31, 2021, and represented 32.5% of total deposits; money market accounts increased 95.6% compared to a year ago to $495.3 million, and represented 34.5% of total deposits; and certificates of deposit decreased 19.9% compared to a year ago to $287.2 million at quarter-end, and represented 20.0% of total deposits.

“Deposit balances remain at record levels as we experienced growth with existing customers and developed new deposit relationships,” said Bullard. “We strategically increased noninterest-bearing and other core deposits to manage overall funding costs. We lowered our total cost of funds over the quarter by shifting our deposit mix more toward non-maturity deposits.” Total cost of funds improved to 0.32% for the first quarter of 2021 compared to 0.38% for the fourth quarter of 2020.

Deposits consisted of the following at the dates indicated:

    March 31,
2021
  December 31,
2020
  March 31,
2020
  Three
Month
Change
  One Year
Change
     
    (In thousands)
Savings   $ 186,173   $ 164,434   $ 165,747   $ 21,739     $ 20,426  
Transaction accounts     466,143     431,171     286,283     34,972       179,860  
Money market accounts     495,265     429,143     253,198     66,122       242,067  
Certificates of deposit     287,226     308,769     358,677     (21,543 )     (71,451 )
Total deposits   $ 1,434,807   $ 1,333,517   $ 1,063,905   $ 101,290     $ 370,902  

On March 25, 2021, the Company completed its private placement of $40.0 million of 3.75% fixed-to-floating rate subordinated notes due 2031 (the “Notes”) to certain qualified institutional buyers and accredited investors. The Notes have been structured to qualify as Tier 2 capital for the Company for regulatory capital purposes. The Company intends to use the net proceeds of the offering for general corporate purposes and provided $20.0 million to the Bank as Tier 1 capital. “We believe this capital will serve us well as we continue to grow the Company and enhance our footprint and product offerings,” said Deines.

Total shareholders’ equity was $182.1 million at March 31, 2021, compared to $186.4 million three months earlier, and $167.2 million a year earlier. The decrease in equity was driven by reduced other comprehensive income of $5.2 million due to a decrease in the unrealized gain on investments of $3.5 million and a $1.7 million adjustment reflecting the recognition of prior service cost related to First Fed’s transfer out of a multiemployer pension plan into a single employer plan. The decrease in equity compared to the prior quarter was also a result of stock buybacks during the first quarter of 2021. Book value per common share was $17.86 at March 31, 2021, compared to $18.20 at December 31, 2020 and $16.02 at March 31, 2020.

Operating Results

In the first quarter of 2021, the Company generated a return on average assets (“ROAA”) of 0.76%, and a return on average equity (“ROAE”) of 6.70%, compared to 0.97% and 8.32%, respectively, in the fourth quarter of 2020, and 0.27% and 1.94%, respectively, in the first quarter a year ago.

Total interest income increased to $14.6 million for the first quarter of 2021, compared to $14.0 million in the previous quarter and $12.0 million in the first quarter of 2020. Interest and fees on loans increased due to loan growth compared to the prior quarter. Quarter over quarter, the yield on average loans receivable increased by 2 basis points. Total interest expense was $1.2 million for the first quarter of 2021, compared to $1.3 million in the fourth quarter of 2020, and $2.6 million in the first quarter a year ago. The decrease in interest expense was due to the decline in the cost of total deposits to 27 basis points from 34 basis points in the prior quarter and 85 basis points the first quarter one year ago.

Net interest income, before provision for loan losses, increased 6.4% during the quarter to $13.5 million, compared to $12.7 million for the preceding quarter, and increased 43.3% compared to $9.4 million in the first quarter a year ago. “The first round of PPP expired on August 8, 2020, and as of March 31, 2021, we received from the SBA proceeds on forgiven loans totaling $16.6 million. Approximately $177,000 of the income recognized during the first quarter was related to deferred fees associated with PPP loan payoffs, compared to $182,000 of the income related to deferred fees associated with PPP loan payoffs in the prior quarter,” added Riffle.

While asset quality improved during the last twelve months, additional loan growth and the anticipated impact of the COVID-19 pandemic on local businesses resulted in a $500,000 provision for loan losses during the first quarter of 2021. This compares to a provision for loan losses of $930,000 for the preceding quarter, and a provision for loan losses of $1.3 million for the first quarter of 2020.

The net interest margin expanded 2 basis point to 3.48% for the first quarter of 2021, compared to 3.46% for the fourth quarter of 2020, and increased 37 basis points compared to 3.11% for the first quarter in 2020. “Despite a challenging interest rate environment, our earning asset mix enhancements as well as substantially reducing our cost of funds helped increase our net interest margin over the past twelve months,” said Bullard.

The yield on earning assets decreased 3 basis points to 3.78% for the first quarter of 2021, compared to 3.81% for the fourth quarter of 2020, and decreased 19 basis points from 3.97% for the first quarter of 2020. The decrease was due to lower yields on the investment portfolio and loans, which was offset by higher average loan balances. The yield on the loan portfolio increased to 4.43% for the first quarter of 2021, from 4.41% for the fourth quarter of 2020, and decreased from 4.52% for the first quarter of 2020 due to a decline in the overall rate environment. The cost of interest-bearing liabilities decreased 7 basis points to 0.40% for the first quarter of 2021, compared to 0.47% for the fourth quarter of 2020, and decreased 71 basis points from 1.11% for the first quarter in 2020.

Noninterest income decreased 41.7% to $2.7 million for the first quarter of 2021 from $4.6 million for the fourth quarter of 2020 and increased 16.7% compared to $2.3 million for the first quarter a year ago. The first quarter of 2021 included a $1.3 million gain on sale of loans compared to a $2.3 million gain on sale of loans in the preceding quarter and a $383,000 gain on sale of loans in the first quarter a year ago. Noninterest income growth during the fourth quarter of 2020 also included a $912,000 gain on sale of investment securities. Loan and deposit service fees, the second largest component of noninterest income, totaled $837,000 for the first quarter 2021, compared to $940,000 for the preceding quarter and $881,000 for the first quarter a year ago.

Noninterest expense totaled $12.1 million for the first quarter of 2021, compared to $11.7 million for the preceding quarter and $9.4 million for the first quarter a year ago. The quarterly increase reflects higher compensation expense, including salaries, commissions and benefits. Also impacting operating expenses for the first quarter was the implementation of new technology enhancements for loan and deposit account applications through the use of digital and mobile banking products.

Capital Ratios and Credit Quality

Capital levels for both the Company and its operating bank, First Fed, remain in excess of applicable regulatory requirements and the Bank was categorized as “well-capitalized” at March 31, 2021. Common Equity Tier 1 and Total Risk-Based Capital Ratios at March 31, 2021, were 15.1 % and 16.3%, respectively. The Company distributed $20.0 million to the Bank as Tier 1 capital.

Nonperforming loans decreased to $2.1 million at March 31, 2021, from $2.3 million at December 31, 2020. The percentage of the allowance for loan losses to nonperforming loans increased to 668.1%, at March 31, 2021, from 609.2% at December 31, 2020, and 622.4% at March 31, 2020. Classified loans increased $6.6 million during the current quarter to $14.1 million at March 31, 2021, due to one substandard commercial real estate loan. The allowance for loan losses as a percentage of total loans was 1.2% at March 31, 2021, which was unchanged compared to three months and one year earlier.

About the Company

First Northwest is a bank holding company that primarily engages in the business activity of its subsidiary, First Fed. First Fed is a community-oriented financial institution serving Clallam, Jefferson, Kitsap, Whatcom, and King counties in Washington, through its Seattle lending center and ten full-service branches. Our business and operating strategy is focused on building sustainable earnings through hiring experienced bankers, geographic expansion, diversifying our loan product mix, expanding our deposit product offerings that deliver value-added solutions, enhancing existing services and digital service delivery channels, and enhancing our infrastructure to support the changing needs and expectations of our customers.



FIRST NORTHWEST BANCORP AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except share data) (Unaudited)

    March 31,
2021
    December 31,
2020
    March 31,
2020
    Three
Month
Change
    One Year
Change
 
Assets                                        
                                         
Cash and due from banks   $ 15,827     $ 13,508     $ 15,531       17.2 %     1.9 %
Interest-bearing deposits in banks     83,444       51,647       91,633       61.6       -8.9  
Investment securities available for sale, at fair value     393,495       364,296       317,520       8.0       23.9  
Loans held for sale     4,037       3,753       4,531       7.6       -10.9  
Loans receivable (net of allowance for loan losses of $14,265, $13,847, and $10,830)     1,156,439       1,141,969       899,154       1.3       28.6  
Federal Home Loan Bank (FHLB) stock, at cost     3,997       5,977       7,581       -33.1       -47.3  
Accrued interest receivable     6,251       6,966       4,124       -10.3       51.6  
Premises and equipment, net     14,795       14,785       14,231       0.1       4.0  
Mortgage servicing rights, net     2,309       2,120       843       8.9       173.9  
Bank-owned life insurance, net     38,596       38,353       30,355       0.6       27.1  
Prepaid expenses and other assets     17,103       10,975       11,436       55.8       49.6  
                                         
Total assets   $ 1,736,293     $ 1,654,349     $ 1,396,939       5.0 %     24.3 %
                                         
Liabilities and Shareholders’ Equity                                        
                                         
Deposits   $ 1,434,807     $ 1,333,517     $ 1,063,905       7.6 %     34.9 %
FHLB advances     50,000       109,977       150,021       -54.5       -66.7  
Subordinated debt     39,310                   100.0       100.0  
Accrued interest payable     84       53       194       58.5       -56.7  
Accrued expenses and other liabilities     27,994       23,303       15,225       20.1       83.9  
Advances from borrowers for taxes and insurance     2,000       1,116       443       79.2       351.5  
                                         
Total liabilities     1,554,195       1,467,966       1,229,788       5.9       26.4  
                                         
Shareholders’ Equity                                        
Preferred stock, $0.01 par value, authorized 5,000,000 shares, no shares issued or outstanding                       n/a       n/a  
Common stock, $0.01 par value, authorized 75,000,000 shares; issued and outstanding 10,195,644 at March 31, 2021; issued and outstanding 10,247,185 at December 31, 2020; and issued and outstanding 10,432,963 at March 31, 2020     102       102       104       0.0       -1.9  
Additional paid-in capital     96,499       97,412       99,479       -0.9       -3.0  
Retained earnings     94,363       92,657       85,549       1.8       10.3  
Accumulated other comprehensive income (loss), net of tax     199       5,442       (8,256 )     -96.3       102.4  
Unearned employee stock ownership plan (ESOP) shares     (9,065 )     (9,230 )     (9,725 )     1.8       6.8  
                                         
Total shareholders’ equity     182,098       186,383       167,151       -2.3       8.9  
                                         
Total liabilities and shareholders’ equity   $ 1,736,293     $ 1,654,349     $ 1,396,939       5.0 %     24.3 %





FIRST NORTHWEST BANCORP AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF INCOME
(Dollars in thousands, except per share data) (Unaudited)

    Quarter Ended                  
    March 31,
2021
    December 31,
2020
    March 31,
2020
    Three
Month
Change
    One Year
Change
 
INTEREST INCOME                                        
Interest and fees on loans receivable   $ 12,541     $ 11,894     $ 9,836       5.4 %     27.5 %
Interest on mortgage-backed and related securities     464       437       959       6.2       -51.6  
Interest on investment securities     1,570       1,581       1,069       -0.7       46.9  
Interest on deposits in banks     13       9       68       44.4       -80.9  
FHLB dividends     45       56       47       -19.6       -4.3  
Total interest income     14,633       13,977       11,979       4.7       22.2  
                                         
INTEREST EXPENSE                                        
Deposits     934       1,079       2,138       -13.4       -56.3  
FHLB advances     191       221       434       -13.6       -56.0  
Subordinated debt     25                   100.0       100.0  
Total interest expense     1,150       1,300       2,572       -11.5       -55.3  
                                         
Net interest income     13,483       12,677       9,407       6.4       43.3  
                                         
PROVISION FOR LOAN LOSSES     500       930       1,266       -46.2       -60.5  
                                         
Net interest income after provision for loan losses     12,983       11,747       8,141       10.5       59.5  
                                         
NONINTEREST INCOME                                        
Loan and deposit service fees     837       940       881       -11.0       -5.0  
Mortgage servicing fees, net of amortization     30       146       15       -79.5       100.0  
Net gain on sale of loans     1,337       2,324       383       -42.5       249.1  
Net gain on sale of investment securities           912       605       -100.0       -100.0  
Increase in cash surrender value of bank-owned life insurance     244       249       328       -2.0       -25.6  
Other income     256       67       106       282.1       141.5  
Total noninterest income     2,704       4,638       2,318       -41.7       16.7  
                                         
NONINTEREST EXPENSE                                        
Compensation and benefits     7,295       7,193       5,361       1.4       36.1  
Data processing     739       691       690       6.9       7.1  
Occupancy and equipment     1,623       1,663       1,351       -2.4       20.1  
Supplies, postage, and telephone     242       236       211       2.5       14.7  
Regulatory assessments and state taxes     261       271       174       -3.7       50.0  
Advertising     445       572       272       -22.2       63.6  
Professional fees     522       408       400       27.9       30.5  
FDIC insurance premium     148       89             66.3       100.0  
FHLB prepayment penalty                 210       n/a       -100.0  
Other     819       596       713       37.4       14.9  
Total noninterest expense     12,094       11,719       9,382       3.2       28.9  
                                         
INCOME BEFORE PROVISION FOR INCOME TAXES     3,593       4,666       1,077       -23.0       233.6  
                                         
PROVISION FOR INCOME TAXES     473       850       204       -44.4       131.9  
                                         
NET INCOME   $ 3,120     $ 3,816     $ 873       -18.2 %     257.4 %
                                         
Basic and diluted earnings per common share   $ 0.34     $ 0.41     $ 0.09       -17.1 %     277.8 %





FIRST NORTHWEST BANCORP AND SUBSIDIARY

Selected Financial Ratios and Other Data
(Unaudited)

    As of or For the Quarter Ended
    March 31,
2021
  December 31,
2020
  September 30,
2020
  June 30,
2020
  March 31,
2020
Performance ratios: (1)                                        
Return on average assets     0.76 %     0.97 %     0.99 %     0.56 %     0.27 %
Return on average equity     6.70       8.32       8.22       4.60       1.94  
Average interest rate spread     3.38       3.35       3.22       2.90       2.86  
Net interest margin (2)     3.48       3.46       3.36       3.10       3.11  
Efficiency ratio (3)     74.7       67.7       60.9       72.3       80.0  
Average interest-earning assets to average interest-bearing liabilities     134.6       131.7       130.9       129.5       130.1  
Book value per common share   $ 17.86     $ 18.20     $ 17.65     $ 17.07     $ 16.02  
                                         
Asset quality ratios:                                        
Nonperforming assets to total assets at end of period (4)     0.1 %     0.1 %     0.2 %     0.2 %     0.2 %
Nonperforming loans to total loans (5)     0.2       0.2       0.3       0.3       0.2  
Allowance for loan losses to nonperforming loans (5)     668.1       609.2       419.9       360.8       622.4  
Allowance for loan losses to total loans     1.2       1.2       1.2       1.2       1.2  
Net charge-offs to average outstanding loans                              
                                         
Capital ratios (First Fed):                                        
Tier 1 leverage   11.2     10.3 %     10.5 %     10.9 %     11.8 %
Common equity Tier 1 capital   15.1       13.4       14.7       15.1       16.8  
Tier 1 risk-based   15.1       13.4       14.7       15.1       16.8  
Total risk-based   16.3       14.6       16.0       16.4       18.1  
                                         
Other Information:                                        
Average total assets   $ 1,645,806     $ 1,567,521     $ 1,488,723     $ 1,401,500     $ 1,287,529  
Average total loans     1,144,230       1,089,505       1,009,210       938,646       876,135  
Average interest-earning assets     1,549,316       1,466,103       1,401,090       1,305,437       1,208,314  
Average noninterest-bearing deposits     283,204       245,024       218,615       196,698       159,214  
Average interest-bearing deposits     1,092,114       1,032,608       1,009,041       936,968       849,196  
Average interest-bearing liabilities     58,629       80,731       61,244       71,170       79,659  
Average equity     186,171       183,424       178,887       172,009       179,614  
Average shares – basic     9,094,354       9,214,965       9,257,252       9,373,253       9,624,727  
Average shares – diluted     9,185,725       9,258,109       9,263,975       9,408,123       9,676,377  

(1)   Performance ratios are annualized, where appropriate.
(2)   Net interest income divided by average interest-earning assets.
(3)   Total noninterest expense as a percentage of net interest income and total other noninterest income.
(4)   Nonperforming assets consists of nonperforming loans (which include nonaccruing loans and accruing loans more than 90 days past due), real estate owned and repossessed assets.
(5)   Nonperforming loans consists of nonaccruing loans and accruing loans more than 90 days past due.

Contact:
Matthew P. Deines, President and Chief Executive Officer
Geri Bullard, EVP and Chief Financial Officer
First Northwest Bancorp
360-457-0461



Tetra Tech Reports Strong Second Quarter 2021 Results

Tetra Tech Reports Strong Second Quarter 2021 Results

  • Revenue $755 million and Net Revenue $600 million
  • Operating Margin up 114 basis points Y/Y
  • EPS $0.83, up 26% Y/Y
  • Cash from Operations increased to $124 million, up 23% Y/Y
  • Increased quarterly dividend by 18% to $0.20

PASADENA, Calif.–(BUSINESS WIRE)–
Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services, today announced results for the second quarter ended March 28, 2021.

Second Quarter Results

Revenue in the second quarter totaled $755 million and revenue, net of subcontractor costs (net revenue)1, was $600 million. Operating income was $61 million, up 28% year-over-year, driven by a 114 basis point increase in operating margin. Earnings per share (“EPS”) was $0.83, up 26% year-over-year. Cash generated from operations was a record $124 million, up 23% year-over-year. Backlog at the end of the quarter was $3.15 billion, up 5% year-over-year.

Quarterly Dividend and Share Repurchase Program

On April 26, 2021, Tetra Tech’s Board of Directors declared a $0.20 per share quarterly dividend, an 18% increase over the prior year, payable on May 28, 2021 to stockholders of record as of May 12, 2021; the seventh consecutive double-digit annual increase. In the second quarter, Tetra Tech repurchased $15 million of common stock. Additionally, as of March 28, 2021, the Company had $178 million remaining under the approved share repurchase program.

Chairman and CEO Comments

Tetra Tech’s Chairman and CEO, Dan Batrack, commented, “Tetra Tech continued to build on its strong start to fiscal year 2021, generating record second quarter revenue and operating income on higher margins in both our government and commercial businesses. We achieved year-over-year double digit revenue growth for our U.S. state & local and U.S. federal water and environmental services by leveraging our Tetra Tech Delta suite of advanced data analytics and digital water technologies. We continued to invest in these strategic growth areas by adding Coanda Research & Development and IBRA-RMAC, leaders in computational fluid dynamics and digital water transformation. Given our results to date and outlook, we are increasing guidance for both net revenue and EPS for fiscal 2021.”

1 Non-GAAP financial measures which the Company believes provide valuable perspectives on its business results. Refer to Reconciliation of GAAP and non-GAAP Item.

Six-Month Results

Revenue for the six-month period was $1.52 billion and net revenue was $1.20 billion. Operating income was $127 million, up 15% compared to the same period in fiscal 2020, and EPS increased 19% to $1.79. Cash flow from operations was $157 million, up 89% year-over-year.

Business Outlook

The following statements are based on current expectations. These statements are forward looking and the actual results could differ materially. These statements do not include the potential impact of transactions that may be completed or developments that become evident after the date of this release. The Business Outlook section should be read in conjunction with the information on forward-looking statements at the end of this release.

Tetra Tech expects EPS for the third quarter of fiscal 2021 to range from $0.85 to $0.90 and net revenue to range from $600 million to $650 million. For fiscal 2021, Tetra Tech is increasing its guidance outlook and now expects EPS to range from $3.60 to $3.70 and net revenue to range from $2.45 billion to $2.55 billion.2

Webcast

Investors will have the opportunity to access a live audio-visual webcast and supplemental financial information concerning the second quarter fiscal 2021 results through a link posted on the Company’s website at tetratech.com on April 29, 2021 at 8:00 a.m. (PT).

Reconciliation of GAAP and Non-GAAP Item

In thousands

 

 

Three Months Ended

 

Six Months Ended

 

March 28, 2021

 

March 29, 2020

 

March 28, 2021

 

March 29, 2020

 

 

 

 

 

 

 

 

Revenue

$

754,764

 

 

$

734,133

 

 

$

1,519,868

 

 

$

1,531,756

 

Subcontractor Costs

 

(154,939

)

 

 

(149,673

)

 

 

(314,873

)

 

 

(333,274

)

Net Revenue

$

599,825

 

 

$

584,460

 

 

$

1,204,995

 

 

$

1,198,482

 

2 Reconciliation of the net revenue guidance to the most directly comparable GAAP measure is not available without unreasonable efforts because the Company cannot predict the magnitude and timing of all the components required to provide such reconciliation with sufficient precision.

About Tetra Tech

Tetra Tech is a leading provider of high-end consulting and engineering services for projects worldwide. With 20,000 associates working together, Tetra Tech provides clear solutions to complex problems in water, environment, sustainable infrastructure, renewable energy, and international development. We are Leading with Science® to provide sustainable and resilient solutions for our clients. For more information about Tetra Tech, please visit tetratech.com, follow us on Twitter (@TetraTech), or like us on Facebook.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The use of words such as “anticipate,” “expect,” “could,” “may,” “intend,” “plan” and “believe,” among others, generally identify forward-looking statements. These forward-looking statements are based on currently available operating, financial, economic and other information, and are subject to a number of risks and uncertainties. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results. A variety of factors, many of which are beyond our control, could cause actual future results or events to differ materially from those projected in the forward-looking statements in this release, including but not limited to: the impact of the COVID-19 pandemic; continuing worldwide political and economic uncertainties; the U.S. Administration’s potential changes to fiscal policies; the cyclicality in demand for our overall services; the fluctuation in demand for oil and gas, and mining services; risks related to international operations; concentration of revenues from U.S. government agencies and potential funding disruptions by these agencies; dependence on winning or renewing U.S. government contracts; the delay or unavailability of public funding on U.S. government contracts; the U.S. government’s right to modify, delay, curtail or terminate contracts at its convenience; compliance with government procurement laws and regulations; credit risks associated with certain clients in certain geographic areas or industries; acquisition strategy and integration risks; goodwill or other intangible asset impairment; the failure to comply with worldwide anti-bribery laws; the failure to comply with domestic and international export laws; the failure to properly manage projects; the loss of key personnel or the inability to attract and retain qualified personnel; the ability of our employees to obtain government granted eligibility; the use of estimates and assumptions in the preparation of financial statements; the ability to maintain adequate workforce utilization; the use of the percentage-of-completion method of accounting; the inability to accurately estimate and control contract costs; the failure to adequately recover on our claims for additional contract costs; the failure to win or renew contracts with private and public sector clients; growth strategy management; backlog cancellation and adjustments; risks relating to cyber security breaches; the failure of partners to perform on joint projects; the failure of subcontractors to satisfy their obligations; requirements to pay liquidated damages based on contract performance; the adoption of new legal requirements; changes in resource management, environmental or infrastructure industry laws, regulations or programs; changes in capital markets and the access to capital; credit agreement covenants; industry competition; liability related to legal proceedings, investigations, and disputes; the availability of third-party insurance coverage; the ability to obtain adequate bonding; employee, agent, or partner misconduct; employee risks related to international travel; safety programs; conflict of interest issues; liabilities relating to reports and opinions; liabilities relating to environmental laws and regulations; force majeure events; protection of intellectual property rights; stock price volatility; the ability to impede a business combination based on Delaware law and charter documents; and other risks and uncertainties as may be described in Tetra Tech’s periodic filings with the Securities and Exchange Commission, including those described in the “Risk Factors” section of Tetra Tech’s Annual Report on Form 10-K for the fiscal year ended September 27, 2020, and Tetra Tech’s Quarterly Reports on Form 10-Q for fiscal year 2021, as well as in Tetra Tech’s other filings with the SEC. Readers should not place undue reliance on forward-looking statements since such information speaks only as of the date of this release. Tetra Tech does not intend to update forward-looking statements and expressly disclaims any obligation to do so.

Non-GAAP Financial Measures

To supplement the financial results presented in accordance with generally accepted accounting principles in the United States (“GAAP”), we present certain non-GAAP financial measures within the meaning of Regulation G under the Securities Exchange Act of 1934, as amended. We provide these non-GAAP financial measures because we believe they provide a valuable perspective on our financial results. However, non-GAAP measures have limitations as analytical tools and should not be considered in isolation and are not in accordance with, or a substitute for, GAAP measures. In addition, other companies may define non-GAAP measures differently which limits the ability of investors to compare non-GAAP measures of Tetra Tech to those used by our peer companies. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures is included in this release.

Jim Wu, Investor Relations

Charlie MacPherson, Media & Public Relations

(626) 470-2844

KEYWORDS: Australia/Oceania United States North America Canada California

INDUSTRY KEYWORDS: Environment Technology Finance Consulting Engineering Telecommunications Professional Services Alternative Energy Manufacturing Energy

MEDIA:

Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS

NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) — Safirstein Metcalf LLP notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. (“Emergent” or “the Company”) (NYSE: EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between July 6, 2020 and March 31, 2021, both dates inclusive (the “Class Period”).

If you purchased or acquired Emergent securities and would like more information, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email [email protected].

If you wish to serve as a lead plaintiff, you must move the Court no later than June 18, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice or may choose to do nothing and remain an absent class member.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) Emergent BioSolution’s Baltimore plant had a history of manufacturing issues increasing the likelihood for massive contaminations; (2) these longstanding contamination risks and quality control issues at Emergent BioSolution’s facility led to a string of FDA citations; (3) the Company previously had to discard the equivalent of millions of doses of COVID-19 vaccines after workers at the Baltimore plant deviated from manufacturing standards; and (4) as a result of the foregoing, defendants’ public statements about Emergent BioSolution’s ability and capacity to mass manufacture multiple COVID-19 vaccines at its Baltimore manufacturing site were materially false and/or misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

About Safirstein Metcalf LLP

Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.

Attorney advertising. Prior results do not guarantee a similar outcome.

Safirstein Metcalf LLP
Peter Safirstein, Esq
1345 Avenue of the Americas
2nd Floor
New York, NY 10105
1-800-221-0015

 



Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella

Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella

DANVERS, Mass.–(BUSINESS WIRE)–
The final results of the physician-led National Cardiogenic Shock Initiative (NCSI) Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used, including placement of an Impella heart pump prior to revascularization (PCI). The study evaluated the outcomes of 406 consecutive patients who presented with acute myocardial infarction cardiogenic shock (AMICS) at 80 participating sites throughout the United States. The study shows a protocol-based approach to increasing survival rates in cardiogenic shock is reproducible in both academic and community hospital settings. Results were presented today by Babar Basir, DO, director of the acute mechanical circulatory support program at Henry Ford Hospital and co-principal investigator of the study, at the 2021 Society of Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210428006079/en/

The NCSI Study is a single-arm, prospective study assessing outcomes associated with early mechanical circulatory support (MCS) in AMICS patients treated with PCI. The goal of the NCSI Study is to increase cardiogenic shock survival, which has historically been approximately 50%, by providing early unloading therapy and allowing the heart to rest prior to PCI, promoting native heart recovery. The NCSI Study prospectively validated the previously identified best practices of identifying shock early, placing Impella support pre-PCI within 90 minutes of arriving at the hospital, using a pulmonary artery catheter to guide decision-making, and reducing the use of inotropes and vasopressors.

The study investigators categorized patients according to SCAI Shock classification stages. For SCAI stages C/D, they found higher survival to discharge (79%), 30-days (77%) and 1-year (62%) compared to historical data in similar patients during the last 30 years. SCAI stage E patients, who are on the brink of cardiovascular collapse, also had improved survival to discharge (54%), 30-days (49%), and 1-year (31%) compared to recent studies of patients who were not treated with the NCSI protocol that published in Journal of American College of Cardiology (33% survival to discharge) and Catherization and Cardiovascular Interventions (22.6% survival to 30-days).

“The NCSI Study demonstrates the benefit of following a protocolized approach to AMICS, which includes early implantation of Impella. We are impressed with the improved survival rates seen with the use of best practices compared to the stagnant historical survival rate,” said Dr. Basir. “It is important to emphasize that the majority of hospitals in the NCSI Study were large community-based programs where heart attack patients first present. Giving these care teams a safe and effective protocol to manage critically ill patients has saved many lives.”

“NCSI is the largest prospective study of therapy for AMICS done in the U.S. in the last 20 years. We have found that the original observations from the Detroit Cardiogenic Shock Initiative have been reproduced showing significantly higher survival rates,” said William O’Neill, MD, medical director of the Henry Ford Health System Center for Structural Heart Disease and co-principal investigator of the study. “If implemented across the country, the NCSI protocol can save 20,000 lives a year.”

Other investigator-led research demonstrates results similar to the NCSI Study results, including the 2019 Inova Study and the 2020 J-PVAD Study. These studies found an 82% and 77% survival at 30 days, respectively, when best practices were followed including the early identification of cardiogenic shock and the early use of Impella. (see figure 1)

“The NCSI Study has shown that, through rapid identification and treatment of patients who will benefit from mechanical circulatory support, higher cardiogenic shock survival rates can be achieved,” said Andrew M. Goldsweig, MD, MS, an assistant professor of interventional cardiology and associate catheterization lab director for structural heart disease at the University of Nebraska Medical Center.

The authors concluded early use of mechanical circulatory support and hemodynamics is associated with improved outcomes. Additional clinical research in the treatment of cardiogenic shock includes the RECOVER IV RCT, which is being developed and will be a prospective, two-arm trial to assess whether Impella pre-PCI is superior to PCI without Impella in AMICS patients. In addition, the DanGer Shock RCT is an ongoing trial in Denmark and Germany assessing primary outcome of death from all causes at six months with Impella CP, compared to standard of care.

To watch Dr. Basir and Dr. O’Neill discuss the NSCI Study results, and the ability of the NCSI protocol to improve outcomes for patients, please visit HeartRecovery.com.

ABOUT IMPELLA HEART PUMPS

The Impella 2.5® and Impella CP® devices are U.S. FDA approved to treat certain advanced heart failure patients undergoing elective and urgent percutaneous coronary interventions (PCI), such as stenting or balloon angioplasty, to reopen blocked coronary arteries.

The Impella 2.5, Impella CP, Impella CP with SmartAssist®, Impella 5.0®, Impella LD®, and Impella 5.5® with SmartAssist® are U.S. FDA approved to treat heart attack or cardiomyopathy patients in cardiogenic shock and have the unique ability to enable native heart recovery, allowing patients to return home with their own heart.

To learn more about the Impella platform of heart pumps, including their approved indications and important safety and risk information associated with the use of the devices, please visit www.abiomed.com.

ABOUT ABIOMED

Based in Danvers, Massachusetts, USA, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. Forward-looking statements are subject to risks and uncertainties such as those described in Abiomed’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Media:

Sarah Lima

Communications Manager

978-882-8211

[email protected]

Investors:

Todd Trapp

Vice President and Chief Financial Officer

(978) 646-1680

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: General Health Health Cardiology Medical Devices

MEDIA:

Logo
Logo
Photo
Photo

SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate PFPT, GRA, NYCB, RMRM; Shareholders are Encouraged to Contact the Firm

NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:


Proofpoint, Inc. (NASDAQ: PFPT)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo for $176.00 per share in cash. If you are a Proofpoint shareholder, click here to learn more about your rights and options.


W. R. Grace & Co. (NYSE: GRA)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Standard Industries Holdings Inc. for $70.00 per share in cash. If you are a W. R. Grace shareholder, click here to learn more about your rights and options.


New York Community Bancorp, Inc. (NYSE: NYCB)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Flagstar Bancorp, Inc. In connection with the merger, Flagstar shareholders are expected to receive New York Community stock. If you are a New York Community shareholder, click here to learn more about your rights and options.


RMR Mortgage Trust (NASDAQ: RMRM)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Tremont Mortgage Trust. RMR Mortgage is expected to issue common stock in connection with the merger. If you are an RMR Mortgage shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]  
https://www.halpersadeh.com



AmpliTech Group Well Positioned to Deliver Amid Global Acceleration of Satellite Launches

PR Newswire

BOHEMIA, N.Y., April 28, 2021 /PRNewswire/ — AmpliTech Group, Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) (the “Company”), a designer, developer, and manufacturer of custom and standard state-of-the-art RF components for 5G/6G Communications, Commercial, SATCOM, Space, Defense, and Military markets.

“AmpliTech manufactures a suite of Low Noise Amplifiers primed to offer companies superior communication solutions.”

AmpliTech has enjoyed the advantage of manufacturing some of the highest performing and most reliable low noise amplifiers available for players in the SATCOM space. As the race to launch Low Earth Orbit (LEO) and Medium Earth Orbit (MEO) accelerates, the need for low noise, low power dissipating, and highly reliable amplifiers grows to be absolutely essential for organizations preparing to launch satellites in coming cycles. Marketwatch reports that the global Satellite Communication (SATCOM) market will reach 30.6 Billion US$ by the end of 2025, growing at a CAGR of 8.3% from 2019 through 2025.

This week Bloomberg reported that SpaceX moved closer to obtaining FCC approval to launch Starlink satellites at a lower orbit to achieve higher service performance. Starlink alone plans to launch up to 42,000 satellites by mid-2027. CNBC reported last week that Amazon will also be looking to commence 9 missions to launch 3,236 satellites in LEO in the near future. LEO and MEO satellite launches aim to increase global connectivity among billions of IoT devices, improve network speed constraints, democratize internet access, and connect people as well as devices in a way never before attainable. It is crucial to ensure mission success by limiting SATCOM component vendors to best-in-breed solutions.

AmpliTech manufactures a suite of Ku, Ka, and X band Low Noise Amplifiers primed to offer companies superior communication solutions. The Ka band LNA operating at 26.5-40 GHZ is preferred for usage in SATCOM devices. AmpliTech’s Ka band LNA features the lowest noise figures in the industry (80K @ room temperature), wide bandwidth, and reduced size wavelength leading to powerful, size efficient devices. This promises high throughput, low interference connectivity for optimal network flow. Superior product design, painstaking quality control, and an aggressive growth strategy has enabled AmpliTech to achieve unparalleled product specifications to push the needle on satellite deployment.

AmpliTech recently secured a $23 million capital raise that will be allocated towards a long-term growth strategy geared towards cementing themselves as a top facilitator of 5G/6G, Commercial, SATCOM, Space, Defense, and Military innovation.

CEO Fawad Maqbool states, “Recent events have proved that the state of the SATCOM industry is at an inflection point for hyper growth. The journey is just beginning and AmpliTech is fortunate to be in a position to push the envelope on satellite technology adoption.”

About AmpliTech Group, Inc.
AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF components for the Domestic and International, SATCOM, Space, Defense and Military markets. These designs cover the frequency range from 50 kHz to 40 GHz – eventually, offering designs up to 100 GHz. AmpliTech also provides consulting services to help with any microwave components or systems design problems. Our steady growth over the past 13+ years has come about because we can provide complex, custom solutions for nearly ANY custom requirements that are presented to us. In addition, we have the best assemblers, wires, and technicians in the industry and can provide contract assembly of customers’ own designs. Website: http://www.AmpliTechinc.com.

Safe Harbor Statement
This release contains statements that constitute forward-looking statements. These statements appear in several places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements because of various factors.

Twitter: https://twitter.com/AmpliTechAMPG
Instagram: https://www.instagram.com/amplitechampg/
Facebook: https://www.facebook.com/AmpliTechInc

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/amplitech-group-well-positioned-to-deliver-amid-global-acceleration-of-satellite-launches-301279199.html

SOURCE AmpliTech Group, Inc.